Date of Document: May 27, 2024
CURRICULUM VITAE

Steven Howard Kroft MD
Chair, Professor
Department of Pathology
Division of Administration

OFFICE ADDRESS:
Froedtert Specialty Clinics
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
09/1982 - 06/1986 BS in Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA
09/1986 - 06/1991 MD, University of Illinois College of Medicine, Chicago, IL

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/1991 - 06/1995 Resident, Pathology AP/CP, McGaw Medical Center of Northwestern University, Chicago, IL
07/1995 - 06/1996 Hematopathology subspecialty training (credentialing year), Pathology, McGaw Medical Center of Northwestern University, Chicago, IL
07/1996 - 06/1997 Hematopathology Fellowship, Pathology, University of Michigan Medical School, Ann Arbor, MI

FACULTY APPOINTMENTS:
08/1997 - 08/2002 Assistant Professor, Pathology, University of Texas, Southwestern Medical School, Dallas, TX
09/2002 - 08/2005 Associate Professor, Pathology, University of Texas, Southwestern Medical School, Dallas, TX
09/2005 - 06/2007 Associate Professor, Pathology, Medical College of Wisconsin, Milwaukee, WI
07/2007 - Present Professor, Pathology, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
10/1997 - 10/2005 Medical Director, Bone Marrow Laboratory, Parkland Memorial Hospital, Dallas, TX
10/1997 - 08/2003 Medical Director, Hematology, Parkland Memorial Hospital, Dallas, TX
01/2001 - 06/2001 Interim Medical Director, Clinical Flow Cytometry Laboratory, University of Texas, Southwestern Medical Center, Dallas, TX
07/2003 - 08/2005 Medical Director, Clinical Flow Cytometry Laboratory Veripath Laboratories, University of Texas, Southwestern Medical Center, Dallas, TX
09/2005 - 11/2011 Medical Director, Hematology, Dynacare Laboratories, Milwaukee, WI
09/2005 - Present Director of Hematopathology, Pathology, Medical College of Wisconsin, Milwaukee, WI
09/2005 - 06/2008 Medical Director, Flow Cytometry, Dynacare Laboratories, Milwaukee, WI
07/2010 - 11/2011 Vice Chair for Education and Academic Affairs, Pathology, Medical College of Wisconsin, Milwaukee, WI
12/2011 - 12/2018 Senior Associate Medical Director, Dynacare Laboratories, Milwaukee, WI
12/2011 - 06/2014 Vice Chair for Clinical Pathology, Pathology, Medical College of Wisconsin, Milwaukee, WI
03/2012 - 11/2018 Safety and Quality Officer, Pathology, Medical College of Wisconsin, Milwaukee, WI
08/2013 - Present Laboratory Medical Director, Post-Acute Specialty Hospital, Greenfield, WI
06/2014 - 12/2018 Executive Vice Chair and Director of Clinical Pathology, Pathology, Medical College of Wisconsin, Milwaukee, WI
12/2017 - 11/2018 Laboratory Medical Director, Drexel Town Square
02/2018 - Present Section Medical Director, Flow Cytometry, Wisconsin Diagnostic Laboratories
11/01/2018 - Present Interim Chair, Pathology, Medical College of Wisconsin
12/2018 - Present Medical Director, Wisconsin Diagnostic Laboratories

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
09/2005 - 07/2011 Director, Hematopathology Fellowship Program, Medical College of Wisconsin, Milwaukee, WI
02/2008 - 06/2009 Associate Director, Pathology Residency Program, Medical College of Wisconsin, Milwaukee, WI
06/2009 - 06/2012 Program Director, Pathology Residency Program, Medical College of Wisconsin, Milwaukee, WI
08/2013 - 08/2018 Residency Program Director, Pathology, Medical College of Wisconsin
02/2018 - Present Hematopathology Fellowship Director, Pathology, Medical College of Wisconsin

HOSPITAL STAFF PRIVILEGES:
10/1997 - 08/2005 Zale Lipshy University Hospital, Dallas, TX
10/1997 - 08/2005 Parkland Memorial Hospital, Dallas, TX
10/1997 - 08/2005 Children's Medical Center, Dallas, TX
09/07/2005 - Present Froedtert Memorial Lutheran Hospital, Milwaukee, WI
08/07/2006 - 12/2010 Children's Hospital of Wisconsin, Milwaukee, WI
11/2009 - 01/2014 Community Memorial Hospital, Menomonee Falls, WI
06/16/2016 - Present Children's Hospital of Wisconsin

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Pathology, AP/CP
11/13/1996
None
American Board of Pathology, Hematology
08/13/1997
None
American Board of Pathology, Voluntary Recertification
01/01/2014
01/01/2024
   
Licensure
Number Issue DateExpiration
Wisconsin License
48364
07/07/2005
10/31/2007
    

AWARDS AND HONORS:
05/1986 Phi Beta Kappa
1989 Alpha Omega Alpha Honor Medical Society
06/1991 Finalist, William J. Grove Award for Outstanding Senior Medical Student, University of Illinois College of Medicine
06/1991 MD degree awarded with Honors, University of Illinois College of Medicine
04/1994 - 03/1995 Chief Resident, Department of Pathology, Northwestern University
1998 - 1999 Pathology Resident Teaching Award, University of Texas Southwestern
1998 - 1999 Sophomore Medical Student Outstanding Teacher Award
2000 - 2001 Pathology Resident Teaching Award, University of Texas Southwestern
2003 - 2018 "Best Doctors in America"
2006 - 2019 "Who's Who in America"
2006 "Who's Who in Medicine and Healthcare"
2007 - 2019 "Who's Who in the World"
2007 - 2008 Outstanding Medical Student Educator, Medical College of Wisconsin
2009 - 2013 "Who's Who in Medicine and Healthcare"
2010 - 2011 Outstanding Medical Student Educator, Medical College of Wisconsin
09/2016 - Present Mastership, American Society for Clinical Pathology

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
International Clinical Cytometry Society
United States and Canadian Academy of Pathology
American Society for Clinical Pathology (Fellow)
International Society for Laboratory Hematology
A. James French Society of Pathologists
Association of Pathology Chairs
Wisconsin Society of Pathologists
Society for Hematopathology
College of American Pathologists (Fellow)
American Medical Association
American Society of Hematology

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
12/2002 - 03/2007 Associate Editor, Clinical Cytometry
07/2004 - 10/2007 Associate Editor, Laboratory Medicine
07/2014 - 07/2018 International Journal of Laboratory Hematology, Associate Editor for Flow Cytometry
07/2018 - Present Editor-in-Chief, American Journal of Clinical Pathology
Editorial Board
08/2002 - 07/2018 American Journal of Clinical Pathology
03/2007 - 04/2014 Clinical Cytometry
04/2007 - 06/2014 International Journal of Laboratory Hematology
10/2007 - 08/2012 Laboratory Medicine
04/2009 - Present Annals of Diagnostic Pathology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
04/1998 - 02/2004 Educational Council, Texas Society of Pathologists
01/2002 - 07/2002 Secretary, Young Pathologists Section, Texas Society of Pathologists
07/2002 - 01/2004 Educational Foundation Board, Texas Society of Pathologists
08/2002 - 10/2002 Chair Elect, Young Pathologists Section, Texas Society of Pathologists
09/2002 - 08/2005 Residents'/Fellows' Seminar Committee, Texas Society of Pathologists
10/2002 - 01/2004 Chair, Young Pathologists Section, Texas Society of Pathologists
10/2002 - 01/2004 Board of Directors, Texas Society of Pathologists
07/2007 - 11/2008 Chief Medical Officer, Search Committee, Blood Center of Wisconsin
10/2009 - 06/2012 Board of Directors, Wisconsin Society of Pathologists
08/2013 - 08/2018 Board of Directors, Wisconsin Society of Pathogists

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
06/1998 - 02/2003 Member, Hematology/Clinical Microscopy Resource Committee, College of American Pathologists
01/1999 - 10/2005 Member, Quality Management Hematopathology Committee (Checkpath), American Society for Clinical Pathology
06/2002 - 09/2002 ASCP Program Committee, Society for Hematopathology
02/2003 - 12/2005 Vice Chair, Hematology/Clinical Microscopy Resource Committee, College of American Pathologists
09/2003 - 09/2004 Chair, ASCP Program Committee, Society for Hematopathology
03/2005 - 03/2006 Membership Committee, Society for Hematopathology
03/2006 - 03/2007 Chair, Membership Committee, Society for Hematopathology
10/2006 - 10/2011 Member at Large, Board of Directors, American Society for Clinical Pathology
2006 Chair, Hematology/Clinical Microscopy Resource Committee, College of American Pathologists
10/2007 - 10/2009 Chair, Commission on Assessment, American Society for Clinical Pathology
10/2007 - 06/2008 ASCP Task Force on Communication, American Society for Clinical Pathology
02/2008 - 10/2010 Representative, Council of Medical Specialty Societies, American Society for Clinical Pathology
09/2008 - 06/2009 Task Force on Transition, American Society for Clinical Pathology
09/2008 - 09/2010 Finance Committee, Council of Medical Specialty Societies
10/2009 - 10/2012 Chair, Commission on Continuing Professional Development, American Society for Clinical Pathology
07/2010 - 06/2011 Task Force on Connectivity, American Society for Clinical Pathology
03/2011 - 02/2015 Representative, Council of Medical Specialty Societies, American Society for Clinical Pathology
07/2011 - 06/2012 Task Force on Governance II, American Society for Clinical Pathology
07/2011 - Present Guideline Advisory Panel for the Work-up of Acute Leukemia, CAP/ASH
09/2011 - Present Ad hoc Quality Committee, ASCP/ASH
10/2011 - Present Ad hoc Workgroup on GME, American Society for Clinical Pathology
10/2011 - 11/2012 Vice President, American Society for Clinical Pathology
11/2012 - 09/2013 Member, Finance Committee, American Society for Clinical Pathology
11/2012 - 09/2013 President-Elect, American Society for Clinical Pathology
11/2012 - 09/2013 Member, Commission on Public Policy, American Society for Clinical Pathology
04/03/2013 Chair, Pathologist Workforce Roundtable, ASCP Leadership Forum
09/2013 - Present Roundtable, Association of Pathology Chairs
09/2013 - 12/2013 Steering Committee, ASCP/CAP/USCAP/APC Workforce Summit
09/2013 - 10/2014 President, American Society for Clinical Pathology
12/2013 - Present Pathologist Work Force Task Force, Association of Pathology Chairs
12/2013 - Present PhD Work Force Task Force, Assocation of Pathology Chairs
08/2014 - Present Member, Effective Test Utilization Committee, American Society for Clinical Pathology
10/2014 - 10/2015 Immediate Past President, American Society for Clinical Pathology
10/2014 - Present Member, Commission on Science, Technology, and Policy, American Society for Clinical Pathology
10/2014 - Present Chair, Nominations Committee, American Society for Clinical Pathology
01/2015 - 01/2018 Practice Committee (ASCP Representative), American Society of Hematology
02/2015 - Present ASCP Alternate Delegate, American Medical Association
03/2015 - Present Member, Critical Values Development Board, American Society for Clinical Pathology
05/2015 - Present Member, Diagnostics and Technology Steering Committee, Partners for Cancer Diagnosis and Treatment in Africa
08/2015 - 03/2016 Co-Chair, Ad-HOC NPQR Member Advisory Group, American Society for Clinical Pathology
11/2015 - 10/2018 Member, Nominations Committee, American Society for Clinical Pathology
02/2016 - Present Co-Chair, ASCP/CAP/ASH Guideline Committee for Evaluation of Malignant Lymphoma
03/2016 - Present Chair, National Pathology Quality Registry Steering Committee, American Society for Clinical Pathology
01/2019 - Present Member, Advocacy Committee, Association of Pathology Chairs

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
The National Myelodysplastic Syndromes Natural History Study
Source:
National Heart, Lung, and Blood Institute (in collaboration with the National Cancer Institute)
Role:
Protocol consult
Dates:
02/2015 - Present
  
Title:
The National Myelodysplastic Syndromes Natural History Study
Source:
National Heart, Lung, and Blood Institute (in collaboration with the National Cancer Institute)
Role:
Central tiebreaker reviewer
Dates:
02/2016 - Present
  
Prior
Peer Review
Title:
Development of 99mTechnetium Scanning as a Quantitative In Vivo Assay to Predict Chemotherapy Drug Resistance and Clinical Outcome in Lymphoma Patients
Source:
MCW Cancer Center Interdisciplinary Research Grant
Role:
Co-Investigator
Dates:
05/2007 - 12/2010
Direct Funds:
$40,000
  
Non-Peer Review
Title:
An open-label, prospective, stratified, randomized, controlled, multi-center, phase IIB study of the impact of Thymoglobulin therapy on transfusion needs of patients with early myelodysplastic syndrome
Source:
Sangstat Pharmaceuticals
Role:
Central Pathology Reviewer
Dates:
07/2000 - 11/2002
Direct Funds:
$10,000
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
S. Kroft, MD, Cytogenetics and Morphology in B-CLL: Insights into Disease Heterogeneity, Department of Pathology, University of Utah, UT, 12/1996
S. Kroft, MD, Primary Splenic Lymphoma: An overview with special attention to small B-cell disorders, Department of Pathology, Northwestern University, Evanston, IL, 02/1997
S. Kroft, MD, Inspector Training Seminar: Hematology, CAP/LAP, Grapevine, TX, 10/2003
S. Kroft, MD, Beyond Kappa and Lambda: Exploring the Potential of Multicolor Flow Cytometry in the Diagnosis of Hematolymphoid Neoplasia, Medical College of Wisconisn, Milwaukee, WI, 12/2004
S. Kroft, MD, Beyond CD45 and Side Scatter: Realizing the Potential of Multicolor Flow Cytometry, Visiting Professorship, Rush Medical College, Department of Pathology, Chicago, IL, 04/09/2007
S. Kroft, MD, Beyond Kappa and Lambda: Exploring the Potential of Multicolor Flow Cytometry in the Diagnosis of Hematolymphoid Neoplasia, Visiting Professorship, University of Illinois College of Medicine, Department of Pathology, Peoria, IL, 04/26/2010
S. Kroft, MD, Update on Peripheral T-cell Lymphoma, Visiting Professorship, University of Texas Southwestern Medical Center, Dallas, TX, 01/10/2013
S. Kroft, M.D., Healthcare Policy and the Future of Laboratory Practice, Grand Rounds, University of Washington, Department of Laboratory Medicine, 05/27/2015
Flow Cytometric Approach to the Diagnosis of Peripheral T-Cell Lymphoma, Visiting Professorship, University of Saskatchawan, Saskatoon, Saskatchawan, 08/2016 - Present
Telemedicine for the Diagnosis of Non-Communicable Diseases in Africa, Grand Rounds, Global Health Week, MCW Department of Pathology, Milwaukee, WI, 11/2017 - Present
Flow Cytometric Evaluation of Mature T-Cell Proliferations: A 20-Year Journey, Steve Chen Lectureship, University of New Mexico, Albuquerque, 05/2018 - Present
 
Regional
S. Kroft, MD, Isolated soft tissue relapse of ALL, Illinois Registry of Anatomic Pathology, IL, 10/1993
S. Kroft, MD, Appendiceal adenocarcinoid metastatic to bilateral ovaries, Illinois Registry of Anatomic Pathology, IL, 11/1993
S. Kroft, MD, Inflammatory pseudotumor of the pancreas, Illinois Registry of Anatomic Pathology, IL, 11/1994
S. Kroft, MD, Low grade Fibromyxoid Sarcoma, Illinois Registry of Anatomic Pathology, IL, 11/1995
S. Kroft, MD, New Applications for Automated Hematology Analyzers, Breakout session, Texas Society of Pathologists New Issues Forum, League City, TX, 08/2001
S. Kroft, MD, The Top 10 Things You Thought You Knew About Hematopathology, Controversies of Hematologic Malignancies, Milwaukee, WI, 03/2012 - 03/2013
S. Kroft, MD, Flow Cytometry For Clinicians, 2nd Annual Controversies in Hematologic Malignancies Symposium, Milwaukee, WI, 03/2013
S. Kroft, M.D., Challenges & Opportunities Facing Pathology: Policy Implications & Organizational Imperatives, Southeastern Association of Pathology Chairs Meeting, Asheville, NC, 10/03/2013
Overview of 2016 WHO Updates, Wisconsin Society of Pathologists Annual Meeting, Madison, WI, 11/2017 - Present
 
National
S. Kroft, MD, Circulating CMV-infected endothelial cells in a renal transplant patient, 5th Annual Progress in Clinical Pathology Course, Dallas, TX, 10/1997
S. Kroft, MD, Pathology referral in the routine hematology laboratory, 6th Annual Progress in Clinical Pathology Course, Dallas, TX, 03/1999
S. Kroft, MD, POEMS Syndrome, 6th Annual Progress in Clinical Pathology Course, Dallas, TX, 03/1999
S. Kroft, MD, Large-Cell Transformation of Mantle Cell Lymphoma, 7th Annual Progress in Clinical Pathology Course, Dallas, TX, 03/2000
S. Kroft, MD, Laboratory Evaluation of Erythropoiesis, 7th Annual Progress in Clinical Pathology Course, Dallas, TX, 03/2000
S. Kroft, MD, Blood Smear Review and Clinical Management: Tales from the Interface, Texas Association for Clinical Laboratory Science-Convention 2000, Dallas, TX, 03/2000
S. Kroft, MD, "Histiocytic Disorders,” “Lymphoid Disorders, and “Drug Effects", ASCP Fall Annual Meetings, Santa Fe, NM, 2000
S. Kroft, MD, Stump the Stars: Problem Solving in Clinical Pathology, ASCP Annual Meeting, Philadelphia, PA, 10/2001
S. Kroft, MD, Biological and Clinical Investigations of Lymphoma, American Society of Hematology Annual Meeting, Orlando, FL, 12/2001
S. Kroft, MD, “Malignant Lymphoma in Bone Marrow.”, ASCP Educational Course: A Practical Approach to Diagnostic Hematologic Problems, Various locations, Annually, 2001 - 2010
S. Kroft, MD, “Histiocytic Disorders,” “Lymphoid Disorders, and “Drug Effects.”, ASCP Fall Annual Meetings, New Orleans, LA, 2001
S. Kroft, MD, Hematopathology Proffered Paper Session, United States and Canadian Academy of Pathology Meeting, Chicago, IL, 02/2002
S. Kroft, MD, Chronic Lymphoid Leukemia Update, 9th Annual Progress in Clinical Pathology Course, Dallas, TX, 04/2002
S. Kroft, MD, Peripheral T-Cell Lymphomas: Classification and Diagnosis, Society for Hematopathology Companion Meeting, Washington, D.C., 10/2002
Hematopathology Proffered Paper Session (Section A, Tuesday AM), United States and Canadian Academy of Pathology Meeting, Washington, D.C., 03/2003
S. Kroft, MD, An Unusual Myelodysplastic Syndrome, 10th Annual Progress in Clinical Pathology Course, Dallas, TX, 03/2003
S. Kroft, MD, Special Studies in Hematology: When You Need Them and How to Interpret the Results, 10th Annual Progress in Clinical Pathology Course, Dallas, TX, 04/2003
S. Kroft, MD, Co-Moderator: Society for Hematopathology Companion Meeting, ASCP/CAP Fall Meeting, New Orleans, LA, 09/2003
S. Kroft, MD, Application of Flow Cytometry to Pediatric Hematopathology, Joint Workshop of the Society for Hematopathology and European Association for Haematopathology, Memphis, TN, 10/2003
S. Kroft, MD, Application of Special Studies in the Diagnosis of Lymphomas, ASCP Educational Course: A Practical Approach to Diagnostic Hematologic Problems, Various locations, Annually, 2003 - 2010
S. Kroft, MD, Persistent Hematogone Hyperplasia, 11th Annual Progress in Clinical Pathology Course, Dallas, TX, 01/2004
S. Kroft, MD, Challenges in blood and bone marrow pathology, ASCP Annual Meetings, Various locations, Annually, 07/2004 - 10/2009
S. Kroft, MD, Co-Moderator: Society for Hematopathology Companion Meeting, ASCP/CAP Fall Meeting, San Antonio, TX, 09/2004
S. Kroft, MD, Dusky Disks, Flow Cytometry Case Presentation, Clinical Cytometry Society Annual Meeting, Long Beach, CA, 10/2004
S. Kroft, MD, Chronic Lymphoproliferative Disorders, ASCP Educational Course: A Practical Approach to Diagnostic Hematologic Problems, Various locations, Annually, 10/2004 - 11/2010
S. Kroft, MD, "Histiocytic Disorders,” “Lymphoid Disorders, and “Drug Effects", ASCP Fall Annual Meetings, New Orleans, LA, 2004
S. Kroft, MD, Co-Moderator: Hematopathology Proffered Paper Session, United States and Canadian Academy of Pathology Meeting, San Antonio, TX, 02/2005
S. Kroft, M.D., Beyond Kappa and Lambda: Exploring the Potential of Multicolor Flow Cytometry in the Diagnosis of Hematolymphoid Neoplasia, 12th Annual Progress in Clinical Pathology Course, Keystone, CO, 07/2005
S. Kroft, MD, Severe Chronic Neutropenia in a Mother and Her Infant, 12th Annual Progress in Clinical Pathology Course, Keystone, CO, 07/2005
S. Kroft, MD, Stump the Stars: Problem Solving in Clinical Pathology, ASCP Annual Meeting, Seattle, WA, 10/2005
S. Kroft, MD, "Histiocytic Disorders,” “Lymphoid Disorders, and “Drug Effects", ASCP Fall Annual Meetings, Hilton Head, SC, 2005
S. Kroft, MD, Benign mimics of lymphoid neoplasia. Workshop on Non-Neoplastic Hematopathology of Bone Marrow for the Practicing Pathologist, ASCP Annual Meetings, Various locations, Annually, 2006 - 2008
S. Kroft, MD, Flow Cytometry in the Diagnosis and Classification of Hematologic Neoplasia, Weill Medical College of Cornell University, Various locations, Annually, 2007 - 2020
S. Kroft, MD, Problem Cases in Hematopathology, ASCP Annual Meetings, Various locations annually, 2007 - 2010
S. Kroft, MD, WHO Classification of Hematologic Neoplasms 2008 (2009?): What's New and Different, The Midwestern Conference: Update Course in Surgical Pathology, Milwaukee, WI, 09/14/2008
S. Kroft, MD, Special Studies in Hematopathology: When You Need Them and What To Do With the Results, The Midwest Conference: Update in Surgical Pathology, Milwaukee, WI, 09/14/2008
S. Kroft, MD, Update on Peripheral T-cell Neoplasia, The Midwestern Conference: Update Course in Surgical Pathology, Milwaukee, WI, 08/21/2009
S. Kroft, MD, Application of Flow Cytometry to Peripheral T-Cell Neoplasia, The Midwestern Conference: Update Course in Surgical Pathology, Milwaukee, WI, 08/21/2009
S. Kroft, MD, Lunch Roundtable Discussion: Flow cytometry in daily hematopathology practice, ASCP Annual Meeting, Chicago, IL, 10/31/2009
S. Kroft, MD, Hematopathology Specialty Conference, USCAP Annual Meeting, Washington, D.C., 03/21/2010
S. Kroft, MD, Flow Cytometry In The Evaluation And Follow-Up Of Plasma Cell Myeloma, Society for Hematopathology Companion Meeting, USCAP Annual Meeting, Washington, D.C., 03/21/2010
S. Kroft, MD, Update on CLL and Other Lymphoproliferative Disorders, The Midwestern Conference: Update Course in Surgical Pathology, Milwaukee, WI, 05/15/2010
S. Kroft, MD, Hematopathology Stump the Stars, ASCP Annual Meeting, San Francisco, CA, 10/2010
S. Kroft, MD, Castleman’s Disease: Variants and Differential Diagnosis, The Midwestern Conference: Update Course in Surgical Pathology, Milwaukee, WI, 09/2011
S. Kroft, M.D., Small B-Cell Lymphomas and lymphoproliferative disorders, ASCP Educational Course: A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, Various Locations, annually, 2011 - 2016
S. Kroft, MD, Stump the Stars: Problem Cases in Hematopathology, ASCP Annual Meeting, Las Vegas, NV, 2011
S. Kroft, MD, Peripheral T-Cell Lymphomas, ASCP Educational Course: A Practical State-of-the-Art Approach to Diagnostic Hematologic Problems, Various locations, Annually, 2011 - 2016
S. Kroft, MD, Application of Immunohistochemistry and Flow Cytometry in the Diagnosis of Hematolymphoid Neoplasia, ASCP Educational Course: A Practical State-of-the-Art Approach to Diagnostic Hematologic Problems, Various locations, Annually, 2011 - 2016
S. Kroft, MD, Splenic B-Cell Lymphomas: An Update, The Midwestern Conference: Update Course in Surgical Pathology, Milwaukee, WI, 09/2012
S. Kroft, M.D., The Art of Scientific Writing and Manuscript Review, ASCP Annual Meeting, Boston, MA, 10/2012
S. Kroft, M.D., Lunch Breakout Session: The Role of academic pathology in building and maintaining the technical laboratory workforce of the future, Association of Pathology Chairs Annual Meeting, Boston, MA, 07/11/2013
S. Kroft, M.D., The Essential Laboratory Technical Workforce, Association of Pathology Chairs Annual Meeting, Boston, MA, 07/12/2013
S. Kroft, M.D., Breakfast Roundtable Discussion: The application of ancillary studies to diagnosis of hematolymphoid neoplasia, ASCP Annual Meeting, Chicago, IL, 09/2013
S. Kroft, M.D., Lymphoma in Bone Marrow, ASCP Educational Course: A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, Various Locations, Annually, 2013 - 2019
S. Kroft, MD, Stump the Stars: Problem Cases in Hematopathology, ASCP Annual Meetings, Chicago, IL, 2013
S. Kroft, M.D., The Essential Laboratory Technical Workforce, Association of Directors of Anatomic and Surgical Pathology, San Diego, CA, 03/01/2014
S. Kroft, M.D., The Pathology Workforce: 5 Reasons Why We Don't Know Where We're Going, Housestaff Specialty Conference, USCAP Annual Meeting, San Diego, CA, 03/02/2014
S. Kroft, M.D., Pathology Leadership Panel: Workforce Issues, CAP Policy Meeting, Washington, D.C., 05/05/2014
S. Kroft, M.D., Laboratory Test Utilization, Council of Medical Specialty Societies Spring Meeting, Council Representatives Forum, Chicao, IL, 05/09/2014
S. Kroft, M.D., The Workforce in Pathology and Laboratory Medicine: Ensuring That Supply Meets Demand by 2020, Association of Pathology Chairs Annual Meeting, Boston, MA, 07/10/2014
S. Kroft, M.D., Non-Hodgkin Lymphoma Involving Bone Marrow: Pearls and Pitfalls, The Midwestern Conference, Milwaukee, WI, 09/14/2014
S. Kroft, M.D., Choosing Wisely: Pathology and Laboratory Medicine Address Utilization, Southeast Association of Pathology Chairs Meeting, Savannah, GA, 10/03/2014
S. Kroft, M.D., Update on Aggressive B-cell Lymphoma, The Midwestern Conference, Milwaukee, WI, 09/13/2015
Policy Revolutions and Evolutions: What Laboratories Have to Fear in 2016 and Beyond., ASCP Annual Meeting, Long Beach, CA, 10/2015 - Present
S. Kroft, M.D., Challenges in the Diagnosis of Monocytic/Histiocytic Disorders in Bone Marrow, ASCP Annual Meeting, Long Beach, CA, 10/2015
S. Kroft, M.D., Stump the Stars: Problem Cases in Hematopathology, ASCP Annual Meeting, Various locations, annually, 2015 - 2018
Course Co-Director, A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, Various locations, annually, 2015 - 2016
A Case of Leukocytosis and Heart Failure, Tutorial on Neoplastic Hematopathology, New Orleans, LA, 01/2016 - Present
Benign mimics of lymphoma: a sampler, The Midwestern Conference: Update Course in Surgical Pathology, Milwaukee, WI, 09/2016 - Present
Minimal Residual Disease Detection by Flow Cytometry: Approach and Clinical Applications in Hematologic Malignancy, ASCP Annual Meeting, Las Vegas, NV, 09/2016 - Present
Telemedicine for the Diagnosis of Hematological Malignancies in Africa, American Society of Hematology Annual Meeting, San Diego, CA, 12/2016 - Present
Acute leukemias of ambiguous lineage, A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, Various locations, annually, 2016 - 2019
Using Big Data to Improve Patient Care in the Laboratory: Building the ASCP National Pathology Quality Registry, ASCP Annual Meeting, Chicago, IL, 09/2017 - Present
Application of Immunohistochemistry in the Diagnosis of Hematolymphoid Neoplasia, ASCP Educational Course: A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, Various locations, annually, 2017 - 2019
Small B-Cell Lymphomas and B-cell lymphoproliferative disorders, ASCP Educational Course: A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, Various locations, annually, 2017 - 2019
Peripheral T-cell Lymphomas and T-cell Lymphoproliferative Disorders, ASCP Educational Course: A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, Various locations, annually, 2017 - 2019
Application of Flow Cytometry in the Diagnosis of Hematolymphoid Neoplasia, ASCP Educational Course: A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, 2017 - 2019
Flow cytometry of myeloid malignancies, ASCP Annual Meeting, Various locations, 2017 - 2018
Course Director, A Practical State-of the-Art Approach to Diagnostic Hematologic Problems, Various locations, annually, 2017 - 2019
Co-Moderator: Hematopathology Proffered Paper Session, United States and Canadian Academy of Pathology Meeting, Vancouver, BC, 03/2018 - Present
Keynote Address: Work-up of Lymphoma: Development of the ASCP/CAP/ASH practice guideline, American Association of Pathologists' Assistants Annual Meeting, New Orleans, LA, 09/2018 - Present
Keynote Address: The National Pathology Quality Registry: Using Data to Drive Quality Improvement in the Clinical Laboratory, American Association of Pathologists' Assistants Annual Meeting, New Orleans, LA, 09/2018 - Present
Lymphoma classification: Then and Now, The Midwestern Conference: Update in Surgical Pathology, Milwaukee, WI, 09/2018 - Present
Keynote Address: The Evolution of Lymphoma Classification: A 60-Year History, American Association of Pathologists' Assistants Annual Meeting, New Orleans, LA, 09/2018 - Present
State of the National Pathology Quality Registry, ASCP Annual Meeting, Baltimore, MD, 10/2018 - Present
Lawsuits, CLIA, Labs, and Public Policy: An update of How Government Affects the Pathology and Lab Community, ASCP Annual Meeting, Baltimore, MD, 10/2018 - Present
Gastrointestinal lymphomas, The Midwestern Conference: Update in Surgical Pathology, Milwaukee, WI, 09/2019 - Present
Are These T cells Normal or Abnormal? Flowing T cell Malignancies, ASCP Annual Meeting, Phoenix, AZ, 09/2019 - Present
ASCP-CAP-ASH Workup of Lymphoma Clinical Practice Guideline Interactive Session, ASCP Annual Meeting, Phoenix, AZ, 09/2019 - Present
 
International
S. Kroft, MD, Lymphoproliferative Disorders, Brazilian Congress of Pathology, Curitiba, Brazil, 06/1999
S. Kroft, MD, Myeloproliferative Disorders, Brazilian Congress of Pathology, Curitiba, Brazil, 06/1999
S. Kroft, MD, Minimal Residual Disease in Acute Leukemia, XXIVth International Congress of the International Academy of Pathology, Amsterdam, The Netherlands, 10/20/2002
S. Kroft, MD, Hematopathology Case Presentations, Arkadi M. Rywlin International Pathology Slide Seminar, Tel Aviv, Israel, 06/2013
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Kroft SH, Finn WG, Kaye NE, Peterson LC, The relationship of karyotype and lymphocyte morphology in B-chronic lymphocytic leukemia, United States and Canadian Academy of Pathology Annual Meeting, Washington DC, 03/1996
Kesler MV, Xu Y, Karandikar NJ, McKenna RW, Kroft SH, Flow cytometric comparison of Burkitt and CD10(+) Large B-cell lymphomas, United States and Canadian Academy of Pathology Annual Meeting, San Antonio, TX, 03/2005
Kroft SH, Early Enteropathy-Type T-Cell Lymphoma, SH/EAHP Workshop on T-cell Malignancies, Houston, TX, 10/2005
Kesler MV, Kroft SH, CD4(+) Large Granular Lymphocytic Leukemia, SH/EAHP Workshop on T-cell Malignancies, Houston, TX, 10/2005
Olteanu H, Harrington A, Kroft SH, EBV-Positive Plasmablastic Neoplasm, SH/EAHP Workshop on The Spectrum of Immunoproliferative Disorders and the Border Between B-Cell Lymphoma and Plasma Cell Neoplasms, Cleveland, OH, 09/24/2009
Kroft SH, Eshoa C, Olteanu H, Harrington A, Gamma Heavy Chain Disease, SH/EAHP Workshop on The Spectrum of Immunoproliferative Disorders and the Border Between B-Cell Lymphoma and Plasma Cell Neoplasms, Cleveland, OH, 09/25/2009
Bieliauskas S, Bacon C, Foucar K, Gibson S, Kroft S, Swerdlow S, Eshoa C, Cook J, Gamma heavy chain disease: a morphologic and immunophenotypic study of 10 cases including bone marrow, lymph nodes, and spleen, Platform presentation, USCAP annual meeting, San Antonio, TX, 02/26/2011 - 03/04/2011
Olteanu H, Harrington A, Kroft S, CD200 expression in plasma cell myeloma, Platform presentation, USCAP annual meeting, San Antonio, TX, 02/26/2011 - 03/04/2011
11. Mostafa M, Hartley C, Kroft SH, Harrington AM, The Utility of Flow Cytometry in Cerebrospinal Fluid Diagnosis, USCAP Annual Meeting, National Harbor, MD, 03/2019 - Present
 
International
Kroft SH, McKenna RW, Atypical Nodal and Bone Marrow Transformation of CLL with Stable Peripheral Blood Findings, Joint Workshop of the Society for Hematopathology and European Association for Haematopathology, Barcelona, 09/1999
Kroft SH, Domiati-Saad R, Finn WG, Schnitzer B, Dawson DB, Singleton TP, Ross CW, Precursor B Lymphoblastic Transformation of Low Grade Follicle Center Lymphoma, Joint Workshop of the Society for Hematopathology and European Association for Haematopathology, Barcelona, 09/1999
 

COMMITTEE SERVICE:
Medical College of Wisconsin
09/2005 - Present Residency Committee, Pathology, Medical College of Wisconsin
11/2005 - Present Education Committee, Pathology, Medical College of Wisconsin
09/2006 - 12/2011 Total Quality Management Committee, Dynacare Laboratories
11/2006 Team Member, Fellowship Internal Review Committee, Forensic Pathology
01/2008 - 02/2008 Team Leader, Fellowship Internal Review Committee, Hematology/Oncology
07/2009 - 11/2011 Master Clinician Pathway Council, Medical College of Wisconsin
07/2009 - Present Graduate Medical Education Council
01/2010 - 08/2010 Cancer Center Work Group
09/2010 - Present Research Committee, Pathology, Medical College of Wisconsin
10/2010 - 01/2011 Graduate Medical Education Task Force on Quality Metrics
11/2010 - 11/2011 Vice Chair for Clinical pathology, Search Committee, Medical College of Wisconsin
12/2010 - 01/2011 Team Leader, Child and Adolescent Medicine Psychiatry Fellowship Internal Review Committee
05/06/2011 - 05/07/2011 Chair, Ad Hoc MCWAH Resident Non-Renewal Appeal Panel
01/01/2012 - Present Chair, Laboratory Dyad/Operations Committee, Dynacare Laboratories
01/01/2012 - Present Co-Chair, Laboratory Quality Steering Committee, Dynacare Laboratories
03/2012 - Present Quality Council, Medical College of Wisconsin
08/2012 Finance Committee, Medical College of Wisconsin
01/2013 - Present Laboratory Stewardship Dyad, Physician Member, Froedtert Memorial Lutheran Hospital
06/2015 - Present Adult Fellowship Complements Task Force, Medical College of Wisconsin
12/2015 - 09/2016 Search committee, Chair of Dermatology, Medical College of Wisconsin
03/2016 - 09/2018 Reference Laboratory Steering Committee, Pathology, Medical College of Wisconsin
12/2016 - Present Strategic Planning Committee, Pathology, Medical College of Wisconsin
11/2017 - Present Compensation Committee, Medical College Physicians, Medical College of Wisconsin
03/2018 - Present Chair, Clinical Laboratory Sciences Training Program Exploratory Committee, Medical College of Wisconsin
09/2018 - Present Search committee, Medical Director, Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin
11/2018 - Present Executive Committee of the Faculty, Medical College of Wisconsin
 
Hospital
02/1999 - 11/1999 Director of Clinical pathology, Search Committee, University of Texas, Southwestern Medical Center
08/2000 - 08/2002 Laboratory Services Integration Task Forced, University of Texas, Southwestern Medical Center
12/2000 - 06/2001 Reference Lab Committee, University of Texas, Southwestern Medical Center
08/2003 - 08/2005 Veripath Laboratories Medical Advisory Board, University of Texas, Southwestern Medical Center
09/2003 - 08/2005 Residency Education Committee, University of Texas, Southwestern Medical Center
04/2008 - 12/2010 Clinician Satisfaction Committee, Froedtert Memorial Lutheran Hospital
12/01/2011 - 01/2013 Laboratory Executive Steering Committee, Froedtert Memorial Lutheran Hospital
12/01/2011 - Present Inpatient Leadership Council, Froedtert Memorial Lutheran Hospital
12/01/2011 - 01/2014 Quality Assured Laboratory Services Committee, Froedtert Memorial Lutheran Hospital
02/2014 - 06/2017 Co-Chair, Laboratory Quality Oversight Committee, Froedtert Memorial Lutheran Hospital
02/2014 - 06/2017 Enterprise Lab Steering Committee, Froedtert Memorial Lutheran Hospital
04/2016 - Present Clinical Decision Support Governance Committee, Froedtert Hospital
02/2017 - Present Co-chair, Quality Committee, Wisconsin Diagnostic Laboratories
01/2018 - Present Laboratory Integration Steering Committee, Froedtert Health
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
11/2005 Sophomore Medical Student Lectures: Hemolytic anemias, Introduction to WBC Disorders, Chronic Lymphoproliferative Disorder (50 minutes each)
2005 - 2013 Sophomore Medical Student Lectures: Introduction to anemia, Chronic Lymphoproliferative Disorders, Lymphoma I, Lymphoma II (50 minutes each)
2005 - 2009 Acute Leukemia I, Acute Leukemia II
2007 Sophomore Medical Student Lecture: Introduction to neoplasia (50 minutes)
2008 - 2009 Team Based Learning Session: Hemolytic Anemia
2009 - 2013 Sophomore Medical Student Lectures: Hemolytic anemias, Anemia of decreased red blood cell production
11/2010 Master Clinician Pathway Core Activity: Ordering and Interpreting Laboratory Tests. (3 hours)
12/2013 - Present Sophomore Medical Student Lecture: Disorders of Hemoglobin (30 minutes)
 
Resident and Fellow Education
09/2005 - Present Hematopathology Unknown Conferences [1-to 1.5 hrs, ~20/yr (2005-2008), ~8/yr (2009), 4/yr (2010-present]
10/2005 - Present Hematopathology Lecture Series (1 hour, ~12 hours/yr)
2005 - 2010 Hematopahtology Lecture Series (~12 hours, biannually)
2006 - 2011 Hematopathology Journal Club (1 hour, monthly)
05/26/2011 Facilitator, MCWAH Chief Resident Leadership Symposium
2011 - Present Pathology Department Journal Club (3 minutes, ~3 presentations per year)
05/23/2012 Facilitaor, MCWAH Chief Resident Leadership Symposium
 

EXTRAMURAL TEACHING:
Community/Lay Public
01/2000 University of Texas, Southwestern Medical School, Pathology Seminar Series: “Immunophenotypic analysis of peripheral T-cell lymphoma.
 
Medical Student Education
1998 - 2004 University of Texas, Southwestern Medical School, Sophomore Medical Student Lectures: Anemias, Lymphomas (1 hour each, annually)
1998 - 1999 University of Texas, Southwestern Medical School, Facilitator, small group sessions, Sophomore Pathology Course (6 hours/week for 4 weeks annually)
1998 - 2000 University of Texas Southwestern Medical School, Hematology Case Studies (1 hour, annually)
1998 - 2001 University of Texas, Southwestern Medical School, USMLE Review (Sophomore Medical Students): Hematopathology (90 minutes, annually)
2000 - 2003 University of Texas, Southwestern Medical School, Sophomore Medical Student Lectures: Neoplasia 1, Neoplasia II Neoplasia VI (1 hour each, annually)
2002 - 2003 University of Texas Southwestern Medical School, Hematology Case Studies (1 hour, annually)
2002 - 2004 University of Texas, Southwestern Medical School, Facilitator, small group sessions, Sophomore Pathology Course (6 hours/week for 4 weeks annually)
2004 University of Texas Southwestern Medical School, Lectures, Southwestern School of Medical Technology, Blood Bank Specialists: Structure and Function of Hemoglobin; Disorders of Hemoglobin (1 hour each)
 
Resident and Fellow Education
1993 - 1996 Northwestern University, Section leader, Principles of Human Pathology (Sophomore pathology course)
06/1994 Northwestern University, Departmental Research Conference: “Superficial and invasive urinary bladder cancer: issues of clonality and origin"
04/1996 Northwestern University, Departmental Research Conference: “Using patient data for laboratory quality control"
10/1997 University of Texas, Southwestern Medical School, Hematopathology Case Conference: Follicular lymphoma: uncommon twists in a common disease
1997 - 2004 University of Texas, Southwestern Medical School, Hematopathology Journal Club (1 hour, monthly)
1997 - 2001 University of Texas, Southwestern Medical School, Clinical Pathology Resident Lecture Series: Introduction to Anemia; Common differential diagnoses in anemia; Hemoglobin disorders; Chronic lymphoproliferative disorders; Lymphoma I, Lymphoma II (2 hours each, three times annually)
1997 - 2005 University of Texas, Southwestern Medical School, Flow Cytometry Case Conference (1 hour, weekly)
1997 - 2005 University of Texas, Southwestern Medical School, Hematopathology Unknown conference (1 hour, monthly)
02/1999 University of Texas, Southwestern Medical School, Clinical Pathology Update (for Pathology Residents): The reticulocyte count and beyond: laboratory evaluation of erythropoiesis
10/1999 University of Texas, Southwestern Medical School, Hematopathology Case Conference: Transformation of CLL
11/2001 University of Texas, Southwestern Medical School, Hematology/Hematopathology Rounds: Lymphoma Classification in the 21st Century
03/28/2002 University of Texas, Southwestern Medical School, Hematology/Hematopathology Rounds: New Cell Counter Technology in the Hematology Laboratory
2002 - 2004 University of Texas, Southwestern Medical School, Clinical Pathology Lecture Series: Anemia I-IV, Hemoglobin Disorders I and II, chronic lymphoproliferative disorders I and II (1 hour each, twice annually)
2002 - 2003 University of Texas, Southwestern Medical School, Anatomic Pathology Lecture Series: Non-Hodgkin Lymphoma I-IV (1 hour each, annually)
07/2003 - 08/2005 University of Texas, Southwestern Medical School, Introduction to Flow Cytometry for Hematopathology and Flow Cytometry residents (1 hour, bi-monthly)
2003 - 2004 University of Texas, Southwestern Medical School, Anatomic Pathology Lecture Series: Hodgkin Lymphoma (1 hour, annually)
07/2004 University of Texas, Southwestern Medical School, Hematology/Oncology Lecture Series: Introduction to Flow Cytometry
06/2018 - Present MCWAH, Facilitator, Patient Safety and Professionalism, MCWAH Incoming Housestaff Orientation
 

OTHER EDUCATION/TRAINING:
10/2012 - 03/2013 University of Wisconsin-Milwaukee/Medical College of Wisconsin Faculty Leadership Development Program


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Kim ED, Kroft SH, Dalton DP. Basal cell carcinoma of the penis: case report and review of the literature. J Urol 1994; 152:1557-9
2. Kroft SH, Stryker S, Rao MS. Appendiceal involvement as a skip lesion in ulcerative colitis. Mod Pathol 1994; 7:912-4
3. Kroft SH, Stryker SJ, Winter JN, Ergun G, Rao MS. Inflammatory pseudotumor of the pancreas. Int J Pancreatol 1995;18:277-83.
4. Smith FA, Kroft SH. Exponentially adjusted moving mean procedure for quality control: an optimized patient sample control procedure. Am J Clin Pathol 1996;105:44-51.
5. Kroft SH, Tallman MS, Shaw JM, Thangavelu M, Peterson L. Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2- chlorodeoxyadenosine (2-CdA). Leukemia 1997; 11:170.
6. Kroft SH, Finn WG, Kaye NE, Peterson LC. Isolated 13q14 abnormalities and normal karyotype are associated with typical lymphocyte morphology in B-chronic lymphocytic leukemia. Am J Clin Pathol 1997; 107:275-282.
7. Smith FA, Kroft SH. Optimal procedures for detecting analytical bias using patient samples. Am J Clin Pathol 1997;108:254-268.
8. Kroft SH, Singleton TP, Dahiya M, Ross CW, Schnitzer B, Hsi ED. Absence of occult B-cell clones within traumatically ruptured spleens with expanded marginal zones. Mod Pathol 1997;10:1214-1220.
9. Kroft SH, Finn WG, Singleton TP, Ross CW, Sheldon S, Schnitzer B. Follicular large cell lymphoma with immunoblastic features in a child with Wiskott-Aldrich syndrome: an unusual immunodeficiency-related neoplasm not associated with Epstein-Barr virus. Am J Clin Pathol 1998;110:95-99.
10. Kroft SH, Hsi ED, Ross CW, Schnitzer B, Singleton TS. Evaluation of CD23 expression in paraffin-embedded gastric MALT lymphoma. Mod Pathol 1998; 11:967-970.
11. Finn WG, Kay NE, Kroft SH, Church S, Peterson LC. Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: A sequential study of karyotypic instability in 51 patients. Am J Hematol 1998; 59:223-229.
12. Pooley RJ, Peterson L, Finn WG, Kroft SH. Cytomegalovirus-infected cells in routinely prepared peripheral blood films of immunosuppressed patients. Am J Clin Pathol, 1999;112:108-112.
13. Crook TW, Rogers BB, McFarland RD, Kroft SH, Muretto P, Hernandez JA, Latimer J, McKenna RW. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients. Hum Pathol 2000;31:661-668.
14. Maitra A, Ward PCJ, Kroft SH, Jamal S, Levinson BS, Fishleder AJ, Sendelbach KM, McKenna RW. Cytoplasmic inclusions in leukocytes: an unusual manifestation of cryoglobulinemia. Am J Clin Pathol 2000;113:107-112.
15. Kroft SH, Domiati-Saad R, Finn WG, Schnitzer B, Dawson DB, Singleton TP, Ross CW. Precursor B-lymphoblastic transformation of grade I follicle center lymphoma. Am J Clin Pathol 2000;113:411-418.
16. Kroft SH, Howard MS, Picker LJ, Ansari MQ, Aquino DB, McKenna RW. De novo CD5-positive diffuse large B-cell lymphomas: a heterogeneous group containing an unusual form of splenic lymphoma. Am J Clin Pathol 2000;114:523-533.
17. Wians FH, Urban JE, Keffer, JH, Kroft SH. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status versus transferrin receptor concentration. Am J Clin Pathol 2001;115:112-118.
18. Kroft SH, Dawson DB, McKenna RW. Large-Cell Lymphoma Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Flow Cytometric Analysis of 7 cases. Am J Clin Pathol 2001;115:385-395.
19. Wians FH, Urban JE, Kroft SH, Keffer JH. The effect of second trimester gestational age on soluble transerrin receptor (sTfR) concentration quantified using two commercially available sTfR kits. Clin Chim Acta 2001, 303:75-8.
20. Xu Y, Kroft SH, McKenna RW, Aquino DB. Prognostic significance of tumor-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study of 55 cases. Br J Haematol 2001;112:945-949.
21. Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SH. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and marrow involvement and review of the literature. Am J Clin Pathol 2001;115:868-875.
22. Xu Y, McKenna RW, Molberg KH, Kroft SH. Clinicopathologic analysis of CD10 and bcl-2 expression in diffuse large B-cell lymphoma: identification of a high-risk subset with co-expression of CD10 and bcl-2. Am J Clin Pathol 2001;116:183-190.
23. Karandikar NJ, Aquino DB, McKenna RW, Kroft SH. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome: an immunophenotypic analysis. Am J Clin Pathol 2001;116:204-210.
24. McKenna RW, Washington LJ, Aquino DB, Picker LJ, Kroft SH. Immunophenotypic Analysis of B Lymphocyte Precursors (Hematogones) in 662 Consecutive Bone Marrow Specimens by 4 Color Flow Cytometry. Blood 2001;98:2498-2507.
25. Jamal S, Picker LJ, Aquino DB, McKenna RW, Dawson DB, Kroft SH. Immunophenotypic analysis of peripheral T-cell neoplasms: a multiparameter flow cytometric approach. Am J Clin Pathol 2001;116:512-526.
26. Mues G, Wians FH, Kroft SH. EDTA-induced pseudo gray-platelet syndrome. Laboratory Medicine 2001;32:361-364.
27. Xu Y, McKenna RW, Kroft SH. Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study. Am J Clin Pathol 2002;117:291-300.
28. Wilson KS, McKenna RW, Kroft SH, Dawson DB, Ansari Q, Schneider NR. Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Br J Haematol 2002;116:113-121.
29. Xu Y, McKenna RW, Kroft SH. Comparison of immunohistochemistry and multiparameter flow cytometry with cluster analysis for the detection of CD10 in diffuse large B-cell lymphomas. Mod Pathol 2002;15:413-419.
30. Karandikar NJ, Hotchkiss EC, McKenna RW, Kroft SH. Transient stress lymphocytosis: an immunophenotypic characterization of the most common cause of new adult lymphocytosis in a tertiary care hospital. Am J Clin Pathol 2002;117:819-825.
31. Shivapurkar N, Harada K, Reddy J, Scheuermann R, McKenna RW, Xu Y, Milchgrub S, Kroft SH, Gazdar AF. Presence of SV40 virus DNA sequences in human lymphomas. Lancet 2002;359:851-852
32. Asplund SL, McKenna RW, Howard MS, Kroft SH. Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Surg Pathol 2002;26:624-629.
33. Valdez R, Kroft SH, Schnitzer B, Ross CW, Singleton TP, Peterson LC, Finn WG. Cerebrospinal fluid involvement by mantle cell lymphoma. Mod Pathol 2002;15:1073-1079.
34. Xu Y, McKenna RW, Asplund SL, Kroft SH. Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples. Am J Clin Pathol 2002;118:758-764.
35. Xu Y, McKenna RW, Hoang MP, Collins RH, Kroft SH. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature. Am J Clin Pathol, 2002;119:849-854.
36. Fuda FS, Sigauke E, Cavuoti D, Gander R, Kroft S, Willis MS. Primary amoebic meningoencephalitis. Laboratory Medicine 2002;33:57-60.
37. Willis MS, Wians FH, Kroft SH, Baskin LB. The case of the needle-shaped urine crystals. Laboratory Medicine 2002;33:637-640.
38. Reichard KK, McKenna RW, Kroft SH. Comparative analysis of light chain expression in germinal center cells and mantle cells of reactive lymphoid tissues: a four-color flow cytometric study. Am J Clin Pathol 2003;119:130-136.
39. Pullarkat VA, Buenos-Ramos C, Lai R, Kroft SH, Wilson CS, Pullarkat CS, Bu X, Brynes RK. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: analysis of clinicopathologic features and activating c-Kit mutations. Am J Hematol, 2003;73:12-17.
40. Kroft SH, Asplund SL, McKenna RW, Karandikar NJ. Circulating hematogones in adults: a four-color flow cytometry study of 102 patients. Br J Haematol 2004;126:209-212.
41. Karandikar NJ, Kroft SH, Yegappan S, Rogers B, Aquino V, Lee K, Kumar V, Douek DC, McKenna RW. Immunophenotypic Aberrancy of CD8+ T Cells in Familial Hemophagocytic Lymphohistiocytosis. Blood 2004;104:2007-2009..
42. Takahashi T, Shivapurkar N, , Reddy J, Shigematsu H, Miyajima K, Suzuki M, Toyooka S, Zochbauer-Muller S, Drach J, , Parikh G, Zheng Y, Feng Z, Kroft SH, Timmons C, McKenna RW, Feng Z, Gazdar AF. DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin Cancer Res 2004;10:2928-2935.
43. Shivapurkar N, Takahashi T, Reddy J, Zheng Y, Stastny V, Collins R, Toyooka S, Suzuki M, Parikh G, Asplund S, Kroft SH, Timmons C, McKenna RW, Feng Z, Gazdar AF. Presence of SV4O DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res 2004;64:3757-3760.
44. Chen W, Asplund SL, McKenna RW, Kroft SH. Characterization of incidentally identified minute clonal B-lymphocyte populations in peripheral blood and bone marrow. Am J Clin Pathol 2004;122:588-595.
45. Butcher BW, Wilson K, Kroft S, Collins RH, Bhushan V. Biphenotypic Acute Leukemia with B-lymphoid and Myeloid Differentiation Associated with inv5(q13;q33). Cancer Genet Cytogenet 2005;157:62-66.
46. Asplund SL, McKenna RW, Kroft SH. CD5(+) B-cell neoplasms of indeterminate immunophenotype: a clinicopathologic analysis of 26 cases. Appl Immunohistochem Mol Morpho 2005;13:311-317.
47. Reddy J, Shivapurkar N, Takahashi T, Parikh G, Stastny V, Echebiri C, Crumrine K, Zochbauer-Muller S, Drach J, Zheng Y, Feng Z, Kroft SH, McKenna RW, Gazdar AF. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. Oncogene 2005;24:732-736.
48. Willis MS, Monaghan SA, Miller ML, McKenna RW, Perkins WD, Levinson BS, Bhushan V, Kroft SH. Zinc induced copper deficiency: a report of three cases initially diagnosed on bone marrow examination. Am J Clin Pathol 2005;123:125-131.
49. Xu Y, McKenna RW, Doolittle JE, Hladik CL, Kroft SH. The t(14;18) in diffuse large B-cell lymphoma: correlation with germinal center-associated markers and clinical features. Appl Immunohistochem Mol Morpho 2005;13:116-123.
50. Willis MS, McKenna RW, Peterson LC, Coad J, Kroft SH. Low blast count myelodysplastic syndromes with Auer rods: a clinicopathologic analysis of 9 cases. Am J Clin Pathol 2005;124:191-198.
51. Xu Y, McKenna RW, Karandikar NJ, Pildain AJ, Kroft SH. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol 2005;24:799-806.
52. Rivera-Begeman A, Chamberlain W, Kroft SH. New-onset thrombocytopenia and anemia in a patient with a complex medical history. Laboratory Medicine, 2006;37:24-27.
53. Chen W, Kesler MV, Karandikar NJ, McKenna RW, Kroft SH. Flow cytometric features of angioimmunoblastic T-cell lymphoma. Clinical Cytometry 2006;70B:142-148.
54. Harrington AM, Komorowski R, Kroft SH. An 18-year-old male with shortness of breath and cough. Laboratory Medicine 2006;37:340-342.
55. Xu Y, McKenna RW, Wilson KS, Karandikar NJ, Schultz RA, Kroft SH. Immunophenotypic identification of acute myeloid leukemia with monocytic differentiation. Leukemia 2006;20:1321-1324.
56. Chen W, Karandikar NJ, McKenna RW, Kroft SH. Stability of leukemia-associated immunophenotypes in precursor B lymphoblastic leukemia/lymphoma: a single institution experience. Am J Clin Pathol 2007;127:1-8.
57. Reichard KK, McKenna RW, Kroft SH. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. Mod Pathol 2007;20:310-319.
58. Kesler MV, Paranjape GS, Asplund SL, McKenna RW, Jamal S, Kroft SH. Anaplastic large cell lymphoma: a flow cytometric analysis of 29 cases. Am J Clin Pathol 2007;128:314-322.
59. Yang M, Kroft SH, Chitambar CR. Gene expression analysis of gallium-resistant and gallium-sensitive cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the anti-neoplastic activity of gallium nitrate. Molecular Cancer Therapeutics 2007,6:633-643.
60. Shamah C, Pretell JO, Kroft SH. Pericardial effusion in a 29-year-old HIV(+) man. Laboratory Medicine 2007;38:150-152.
61. Kroft SH. Severe Chronic Neutropenia in a Mother and Her Infant. Laboratory Medicine 2007;38:549-551.
62. Harrington A, Ward. PCJ, Kroft SH. Iron deficiency anemia, beta thalassemia minor, and anemia of chronic disease: a morphologic reappraisal. Am J Clin Pathol 2008;129:466-471.
63. Fenske TS, Benjamin H, Kroft SH, Hohenwalter EJ, Rilling WS. Treatment of diffuse large B-cell lymphoma of the liver with yttrium-90 microsphere embolization. Nat Clin Pract Oncol 2008;5:677-681.
64. Harrington AM, Ward PCJ, Kroft SH. Easy bruising, Cataracts, and Hearing Loss in a 27-Year-Old Female. Laboratory Medicine 2008;39:20-22.
65. Ahmed MS, Kroft SH, Davis NB, King DM, Cheng YC. Long term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma. Leuk Res 2008;32:1476-9.
66. Seegmiller A, Karandikar NJ, Kroft SH, McKenna RW, Xu Y. Over-expression of CD7 in CD4-positive T lymphocytes in Classic Hodgkin Lymphoma. Clinical Cytometry 2009;76:169-174.
67. Pullarkat ST, Pullarkat V, Kroft SH, Wilson CS, Ahsanuddin AN, Mann KP, Thein M, Grody WW, Brynes RK. Systemic Mastocytosis associated with t(8;21)(q22;q22) Acute Myeloid Leukemia. J Hematopathol 2009;2:27-33.
68. Seegmiller AC, Kroft SH, Karandikar NJ, McKenna RW. Characterization of immunophenotypic aberrancies in 200 cases of precursor B acute lymphoblastic leukemia. Am J Clin Pathol 2009;132:940-949.
69. Nand R, Bryke C, Kroft SH, Divgi A, Bredeson C, Atallah E. Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second generation tyrosine kinase inhibitors. Leuk Res 2009;33:1144-1146.
70. Harrington AM, Hari P, Kroft SH. Utility of CD56 Immunohistochemical studies in follow-up of plasma cell myeloma. Am J Clin Pathol 2009;132:60-66.
71. Olteanu H, Harrington AH, Kroft SH. Sperm in peritoneal fluid from a man with ascites: a case report. Cases Journal 2009;2:192.
72. Olteanu H, Karandikar NJ, Eshoa C, Kroft SH. Clinical and laboratory findings in CD4(+) large granular lymphocytoses. Int J Lab Hematol 2010;32:e9-16.
73. Walters MP, Olteanu H, Van Tuinen P, Kroft SH. CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukemia in this cytogenetic sub-group. Br J Haematol 2010;149:292-294.
74. Olteanu H, Schur BC, Bredeson C, Atallah E, Kroft SH. Expression of Natural Killer Receptors in T and NK cells: Comparison of Healthy Volunteers, Stem Cell Transplant Patients and Chemotherapy. Leuk Lymph 2010;51:481-487.
75. MoriceWG, Jevremovic D, Olteanu H, Roden A, Nowakowski G, Kroft SH, Hanson CA, Kurtin PJ. Chronic lymphoproliferative disorder of natural killer cells has distinct sub-types that correlate with functionally distinct mature NK cell subsets. Leukemia 2010;24:881-884.
76. Harrington AM. Olteanu H, Currey A, Kroft SH. Localized bone marrow aplasia following radiation with discrepant peripheral counts. Ann Diag Pathol 2010;14:168-172.
77. Plaza JA, Ortega P, Lynott J, Mullane M, Kroft S, Olteanu H. CD8-positive Primary Cutaneous Anaplastic Large T-Cell Lymphoma (PCALCL): Case Report and Review of this Unusual Variant of PCALCL. Am J Dermatopathol 2010;32:489-491.
78. Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P. Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukemia. Br J Haematol 2010;150:480-481.
79. Harrington AM, Olteanu H, Kroft SH. The specificity of immunophenotypic alterations in blasts in non-acute myeloid disorders. Am J Clin Pathol 2010;134:749-761.
80. Spears MD, Harrington AM, Kroft SH, Olteanu H. Immunophenotypic stability of T-cell large granular lymphocytic leukemia and chronic lymphoproliferative disorder of NK cells by flow cytometry. Br J Haematol 2010;151:97-99.
81. Olteanu H, Fenske TS, Harrington AM, Szabo A, He P, Kroft SH. CD23 expression in follicular lymphoma: clinicopathologic correlations. Am J Clin Pathol 2011;135:46-53.
82. Ward PCJ, Glassy EF, Kroft SH, Krafts KP. A mysterious malady: the Malachowski-Wright-Giemsa stain to the rescue. Biotech Histochem 2011;86:76-81.
83. Olteanu H, Harrington AM, Hari P. Kroft SH. CD200 expression in plasma cell myeloma. Br J Haematol 2011;3:408-411.
84. Spears MD, Olteanu H, Kroft SH, Harrington AM. The immunophenotypic stability of plasma cell myeloma by flow cytometry. Int J Lab Haematol, 2011;33:483-491.
85. Horna P, Olteanu H, Kroft S, Harrington A. Flow cytometric analysis of light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies. Am J Clin Pathol 2011;136:954-959.
86. Buonaccorsi J, Kroft SH, Harrington A, VanTuinen P, Olteanu H. Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32). Ann Diag Pathol 2011;15:385-388.
87. Finn WG, Carter KM, Raich R, Harrington AM, Kroft SH, Hero AO. Immunophenotypic signatures of benign and dysplastic myelopoiesis by cytomic profiling. Clinical Cytometry 2011;80:282-290..
88. Vaughan J, Harrington AM, Hari PN, Kroft SH, Olteanu H. Immunophenotypic Stability of Sezary Cells by Flow Cytometry: Usefulness of Flow Cytometry in Assessing Response to and Guiding Alemtuzumab Therapy. Am J Clin Pathol 2012;137:403-411.
89. Olteanu H, Harrington AM, Hari P, Bredeson C, Kroft SH. High Prevalence of Dapsone-Induced Oxidant Hemolysis in North American Stem Cell Transplant Recipients Without Glucose-6-Phosphate-Dehydrogenase Deficiency. Bone Marrow Transplant 2012;47:399-403.
90. Harrington AM, Olteanu H, Kroft SH. A dissection of the CD45/SS (SS) "blast gate." Am J Clin Pathol 2012;137:800-804.
91. Bieliauskas S, Tubbs RR, Bacon C, Eshoa C, Foucar K, Gibson S, Kroft S, Sohani A, Swerdlow SH, Cook JR. Gamma heavy chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases. Am J Surg Pathol 2012;36:534-543.
92. Olteanu H, Schur B, Harrington A, Kroft S. Time and temperature stability of T-cell subsets Evaluated by a Dual-Platform Method. Am J Blood Res 2012;2:128-135.
93. Olteanu H, Harrington AM, Kroft SH. CD200 expression in non-myeloma immunoproliferative disorders: Clinicopathologic features and comparison with plasma cell myeloma. Am J Clin Pathol 2012;138:867-876.
94. Bailey M, Bennett A, Doyle K, Finn W, Garcia E, Glenn D, Holladay EB, Jacobs J, KROFT S, Patterson S, Petersen J, Schulze M, Tanabe P, Zaleski S. Building a laboratory workforce to meet the future. ASCP Task Force on the Laboratory Professionals Workforce. Am J Clin Pathol 2014, 141:154-167.
95. Gheorge G, Rangarajan HG, Camitta B, Segura A, Kroft S, Southern JF. Pediatric T-cell/histiocyte-rich large B-cell lymphoma: An under-recognized entity? Ann Clin Lab Sci 2015; 45:73-78.
96. Nelson A, Harrington AM, Kroft S, Dahar MA, Hamadani M, Dhakal M. Epstein-Barr virus positive muco-cutaneous ulcer: A rare but real lymphoproliferative disorder. Bone Marrow Transplant 2016;51:300-2.
97. Cogbill CH, Spears MD, van Tuinen P, Harrington AM, Olteanu H, Kroft SH. Specific morphologic and cytogenetic variables affect the flow cytometric yield of plasma cell myeloma cells in bone marrow aspirates. Int J Lab Hematol, 2015 Jul 30.
98. Chang JC, Harrington AM, Olteanu H, VanTuinen P, Kroft SH. Proliferation centers in bone marrow involved by chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a clinicopathologic analysis. Ann Diagn Pathol, 2016;25:15-19.
99. Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt M, Gratzinger D, Hosking P, Olteanu H. Pure erythroid leukemia and erythroblastic sarcoma evolving from myeloproliferative neoplasms and myelodysplastic syndrome. Am J Clin Pathol 2016;145:538-551.
100. Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking P, Kroft SH. Immunophenotypes of Chronic Myelomonocytic Leukemia Subtypes by Flow Cytometry: A Comparison of CMML-1 and CMML-2, Myeloproliferative and Dysplastic, De novo and Therapy-related; and CMML-Specific Cytogenetic Risk Subtypes. Am J Clin Pathol 2016, 146:170-81.
101. Batdorf B, Kroft SH, Hosking PR, Harrington AM, MacKinnon AC, Olteanu H. Evaluation of CD43 Expression in Non-Hematopoietic Malignancies. Ann Diag Pathol 2017,29:23-27.
102. Hartley C, Vaughan JW, Jarzembowski J, Kroft SH. Hosking P, Harrington AM, Olteanu H. CD30(+) Monomorphic Post-Transplant Lymphoproliferative Disorder, Diffuse Large B-cell Lymphoma: Greater Host Regulatory T-Cell Infiltration and More Prevalent Non-Germinal Center Cell Phenotype Suggest Pathophysiology Unique to the Post-Transplant Setting. Am J Clin Pathol, 2017;148:485-493
103. Ronen S, Kroft SH, Olteanu H, et al. Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review. Int J Lab Hematol 2019;41:69-79.
 
Books, Chapters, and Reviews
1. Hoyer JD, Kroft SH (eds.) Atlas of Hemoglobin Disorders. A Compendium Based on Proficiency Testing. Chicago, College of American Pathologists, 2003.
2. Olteanu H, Harrington AM, Kroft SH. Pocket Guides to Surgical Pathology: Lymph Nodes. Demos, New York, 2012.
3. Foucar K, Peterson LC, KROFT SH, McKenna RW. Tumors of the Bone Marrow. AFIP Atlas of Tumor Pathology, Series 4. American Registry of Pathology, MD, in press.
4. McKenna RW, Maiese R, Kroft SH. Disorders of bone marrow. In Sternberg S (ed.). Diagnostic Surgical Pathology, Third edition, New York, Raven Press, 1999.
5. Kroft SH, McKenna RW. Erythrocyte disorders. In McKenna RW, Keffer JH (eds.). Handbook of Clinical Pathology, Second edition. Chicago, ASCP Press, 2000.
6. Kroft SH, McKenna RW. Bone marrow manifestations of Hodgkin's and non-Hodgkin's lymphomas and related disorders. In Knowles DM (ed.). Neoplastic Hematopathology, Second Edition, Baltimore, Williams and Wilkins, 2001.
7. McKenna RW, Kroft SH. Disorders of bone marrow. In Sternberg S. (ed.). Diagnostic Surgical Pathology, Fourth edition, New York, Raven Press, 2004.
8. Kroft SH, Monaghan SA. Red blood cell/hemoglobin disorders. In: Hsi ED, (ed.). Hematopathology. Philadelphia: Elsevier, 2007.
9. Kroft SH, Karandikar NJ. Flow cytometry in the diagnosis of acute leukemias and myelodysplastic/myeloproliferative disorders. In: Keren DF, McCoy JP, Carey JL (eds.). Flow Cytometry in Clinical Diagnosis, 4th edition, Chicago, ASCP Press, 2007.
10. McKenna RW, Kroft SH. Disorders of bone marrow. In Mills SE, Carter D, Greenson JK, Reuter VE, Stoler MH. (ed.). Sternberg's Diagnostic Surgical Pathology, Fifth edition, New York, Raven Press, 2009.
11. McKenna RW, Kroft SH. Plasma cell neoplasms. In Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA (eds). Hematopathology, Saunders, Philadelphia, 2010.
12. Kroft SH, Monaghan SA. Red blood cell/hemoglobin disorders. In: Hsi ED, (ed.). Hematopathology, 2nd ed. Philadelphia: Elsevier, 2012.
13. Kroft SH. Bone marrow. In: Mills SE (ed.). Histology for Pathologists, 4th Edition. Philadelphia: Lippincott Williams & Wilkins, 2012.
14. Reichard KK, Kroft SH. Flow Cytometry in the Assessment of Hematologic Disorders. In Orazi A, Foucar K, Weiss L, Knowles DM (eds). Neoplastic Hematopathology, 3rd Edition, Baltimore, Lippincott, Williams and Wilkins, 2013.
15. KROFT SH, Harrington AM, McKenna RW. Disorders of bone marrow. In Mills SE, Carter D, Greenson JK, Reuter VE, Stoler MH. (ed.). Sternberg's Diagnostic Surgical Pathology, Sixth Edition, Philadelphia, Lippincott Williams & Wilkins/Wolters Kluwer Health, 2015.
16. McKenna RW, KROFT SH. Plasma cell neoplasms. In Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA (eds). Hematopahtology, 2nd Edition. Philadelphia, Saunders, 2016.
17. Kroft SH, Oyasu R. Urinary bladder cancer: mechanisms of development and progression. Lab Invest 1994;71:158-74.
18. Kroft SH, Finn WG, Peterson LC. The pathology of the chronic lymphoid leukaemias. Blood Rev 1995;9:234-50.
19. Kroft, SH. McKenna RW. Histiocytic disorders involving bone marrow. Current Diagnostic Pathology 1997;4:203-209.
20. Kroft SH, Picker LJ. Laboratory diagnosis of chronic T-cell leukemias. CLL:Chronic Lymphocytic Leukemia, October, 1998:1-7.
21. Finn WG, Kroft SH. New classifications for non-Hodgkin's lymphoma. Cancer Treat Res 1999;99:1-26.
22. Kroft SH. CD33 as an immunophenotypic marker for acute leukemia. Biological Therapy of Leukemia: Acute Myeloid Leukemia 2000:1(4):5-8.
23. Kroft SH. Infectious diseases manifested in the peripheral blood. Clin Lab Med 2002;22:253-77.
24. Kroft SH. Minimal residual disease in acute leukemia. Histopathology 2002;41 (suppl. 2):87-92.
25. McKenna RW, Asplund SL, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry. Leuk Lymphoma 2004;45:277-85.
26. Kroft SH. Role of flow cytometry in pediatric hematopathology. Am J Clin Pathol 2004;122(Suppl 1):S19-S32.
27. Foucar K, Kroft SH, McKenna RW, Peterson LC. Tumors of the Bone Marrow. AFIP Atlas of Tumor Pathology, Series 4. American Registry of Pathology, MD, 2016.
28. Kroft SH. Bone marrow. In: Mills SE (ed.). Histology for Pathologists, 5th Edition. Philadelphia: Lippincott Williams & Wilkins, 2019
29. Kroft SH, Harrington AM. Flow cytometry of B-cell neoplasms. Clin Lab Med 2017;37:697-723.
30. Kroft SH. Rosai-Dorfman disease: Familiar yet enigmatic. Semin Diagn Pathol 2016;33:244-253.
31. Foreword for Glassy EF (ed.), Color Atlas of Hematology, 2nd Edition. CAP Press, Chicago, 2018.
 
Editorials, Letters to Editor, Other
1. Runaas L, Kroft SH. "Image Challenge: A Transplant Patient With Visual Disturbance. The Hematologist 2018;15(5).
2. Wians FH, Urban JE, Keffer JH, Kroft SH. Serum transferrin receptor: The authors' reply. Am J Clin Pathol 2001;116:447-449
3. Brown A, Kroft S. National Pathology Quality Registry Drives Improvement in the Lab. Critical Values 2018;11:20-21.
4. Harrington A, Ward. PCJ, Kroft SH. Red cell distribution width in iron deficiency anemia and beta-thalassemia minor: The authors' reply. Am J Clin Pathol 2008;130:314.
5. Brown A, Kroft S. ASCP Launches National Pathology Quality Registry. Critical Values 2017;10-22-24.
6. Harrington AM, Olteanu H, Kroft SH. The Unique Immunophenotype of Double-Hit Lymphomas. Am J Clin Pathol 2011;135:649-650.
7. Olteanu H, Harrington AM, Kroft SH. Immunophenotypic Stability of CD200 Expression in Plasma Cell Myeloma. Am J Clin Pathol 2012;137:1013-1014.
8. KROFT SH. The case of "Association for Molecular Pathology v. Myriad Genetics. Medical Laboratory Observer, June, 2013 (Online Edition).
9. KROFT SH. Teamwork key to reducing lab-results errors. Mod Healthc 2014;44:25.
10. Kroft, SH. Lymphoma transformation: genetic relatedness, stealth lymphomas, and the final frontier. Am J Clin Pathol 2001;116:811-814.
11. Kroft SH. Monoclones, monotypes, and neoplasia: pitfalls in lymphoma diagnosis. Am J Clin Pathol 2004;121:457-459.
12. Kroft SH: Uncovering clinically relevant phenotypic variations in lymphoma: CD23 in mantle cell lymphoma. Am J Clin Pathol 2008;130:159-161.
13. KROFT SH. Stepping Outside the Laboratory to Help Reduce Errors. Modern Healthcare, May 19, 2014.
14. Kroft SH. Q&A: Joint fluid crystal exams. CAP Today 1999;13(3):108-109.
15. Kroft SH. Q&A: Sickle screening methods. CAP Today 2000;14(6):114.
16. Kroft SH. Q&A: “What is meant by 1, 2, 3, and 4-color flow cytometry and which should our laboratory be using for immuunophenotyping hematopoietic processes?” Laboratory Medicine 2000;31:535-536
17. Kroft SH. Q&A: Proper usage of the Miller Disk for Reticulocyte Counting. CAP Today 2000;14(12):62
18. Kroft SH. Q&A: Vortexing of EDTA blood specimens with platelet clumps. CAP Today 2001;15(4):94-95
19. Kroft SH. Q&A: “Are there any methods which increase the chances of seeing positive crystals in synovial fluids?” CAP Today 2001;15:108
20. Kroft SH, McKenna RW. Erythrocyte disorders: autoimmune hemolytic anemia. Laboratory Medicine 2001;32:765-767
21. Kroft SH, McKenna RW. Erythrocyte disorders: iron deficiency anemia. Laboratory Medicine 2001;32:767-769
22. Contributor, Symptoms and Diagnosis of Blood disorders. In The Merck Manual of Medical Information, Home Edition, Second Edition. Whitehouse Station, NJ, Merck Research Laboratories, 2003
23. Kroft SH. Q&A: “Is the Miller disk of great value?” CAP Today 2004;18(4):97
24. Kroft SH. “Is it necessary to re-run critical WBC and Hgb results?” CAP Today 2005;19(5):92
25. Contributor, Color Atlas of Body Fluids, Galagan KA, Blomberg D, Cornbleet PJ, Glassy EF (eds.). Chicago, College of American Pathologists, 2006
26. Kroft SH. Q&A: “What values for hematology should have delta checks to prevent preanalytical errors?” CAP Today 2006;20:78
27. Ward PCJ, McKenna RW, Kroft SH. Images in Haematology: White blood cell changes hyperthermia. Br J Haematol 2007;1138:30
28. Harrington AM, Kroft SH. Morphologic Update: Pencil cells and prekeratocytes in iron deficiency anemia. Am J Hematol 2008;83:927
29. Koethe SM, Kroft SH. Hospital Laboratory Leadership and the “Dyad” Model of Management. Lab Medicine, 2013; 44:168-171
30. KROFT SH. Preserving tissue samples for the ages. Critical Values 2014;6(4):6-8.
31. KROFT SH. Facing (and thriving in) the future: A top ten list. Critical Values 2014;7(1):6-8.
32. KROFT SH. The case for global health. Critical Values 2014;7(2):6-8.
33. KROFT SH. Facing (and thriving in) the future: A top ten list. Advanced Healthcare Network for Laboratory. 4/21/14.
34. KROFT SH. The workforce conundrum. Critical Values 2014;7(3):6-8.
35. Kroft SH. Stratification of Follicular Lymphoma: Time for a Paradigm Shift? Am J Clin Pathol, in press.
36. Kroft SH. The evolution of the clinical pathologist. Am J Clin Pathol 2018;150:283-284.
37. Kroft SH. Stepping Outside the Laboratory to Help Reduce Errors. Modern Healthcare, May 19, 2014.
 
Abstracts
1. Hurtig AL, Park K, Kroft SH. Impact of sickle cell disease on families. Society for Pediatric Psychology annual meeting, March, 1989
2. Kroft SH, Rao MS. Appendiceal involvement as a skip lesion in ulcerative colitis. Poster presentation, United States and Canadian Academy of Pathology annual meeting, San Francisco, March, 1994, (Mod Pathol 1994; 7:62A)
3. Peduto AJ, Miller FH, Fitzgerald SW, Sonin AH, Hoff FL, Kroft SH. Classification of fibromatosis: Imaging findings with pathologic correlates. Poster presentation, Radiologic Society of North America annual meeting, November, 1995
4. Kroft SH, Finn WF, Kay, NE, Peterson, LC. The relationship of karyotype and lymphocyte morphology in B-chronic lymphocytic leukemia. Platform presentation, United States and Canadian Academy of Pathology annual meeting, Washington, D.C., March, 1996 (Mod Pathol 1996; 9:115A)
5. Kroft SH, Singleton TP, Dahiya M, Ross CW, Schnitzer B, Hsi ED. Absence of occult B-cell clones within traumatically ruptured spleens with expanded marginal zones. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Orlando, Fl., March, 1997 (Mod Pathol 1997; 10:128A)
6. Pearsall CP, Kroft S, Ross C, Schnitzer B, Singleton TS. Apoptosis in myelodysplastic syndromes. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Orlando, Fl., March, 1997 (Mod Pathol 1997; 10:132A)
7. Massarani-Wafai R, Hsi ED, Singleton TP, Schnitzer B, Kroft S, Ross CW. Classification of primary thyroid lymphoma according to histologic features. Poster presentation, American Society of Clinical Pathologists Fall Meeting, Philadelphia, PA, September, 1997 (Am J Clin Pathol 1997;108:350)
8. Pooley R, Peterson L, Finn W, Sharma B, Kroft S. Morphologic detection of cytomegalovirus (CMV)-infected endothelial cells in routinely prepared peripheral blood smears. Poster presentation, American Society of Clinical Pathologists Spring Meeting, Los Angeles, April, 1998 (Am J Clin Pathol 1998;109:473)
9. Kroft SH, Hsi ED, Ross CW, Schnitzer B, Singleton TP. CD23 expression in paraffin-embedded gastric malt lymphoma. Poster presentation, American Society of Clinical Pathologists Spring Meeting, Los Angeles, April, 1998 (Am J Clin Pathol 1998;109:477)
10. Wilson KS, Kroft SH, McKenna RW, Schneider NR. Cytogenetics of primary effusion lymphoma (HHV-8-positive body-cavity-based lymphoma). Poster presentation, American Society of Human Genetics Annual Meeting, Denver, October, 1998 (Amer J Hum Genet 1998; 63(suppl):A92)
11. Washington LT, Kroft SH, Wilson KS, Aquino DB. CD56 expression by neutrophils is associated with myeloid disorders. Poster presentation, Texas Society of Pathologists Annual Meeting, Dallas, January 1999
12. Howard MS, McKenna RW, Picker LJ, Kroft SH. The Pathologic Spectrum of De Novo CD5-Positive Diffuse Large B-Cell Lymphoma (DLBCL), Including a Distinct Form of Splenic Lymphoma. Platform presentation, United States and Canadian Academy of Pathology annual meeting, San Francisco, CA, March, 1999 (Mod Pathol 1999; 12:139A)
13. Valdez R, Kroft SH, Schnitzer B, Ross CW, Singleton TP, Peterson LP, Finn WG. Cerebrospinal fluid (CSF) involvement by mantle cell lymphoma. Poster presentation, United States and Canadian Academy of Pathology annual meeting, San Francisco, CA, March, 1999 (Mod Pathol 1999; 12:147A)
14. Washington LT, Ansari MQ, Picker LJ, Aquino DB, Kroft SH, McKenna RW. Immunophenotypic analysis of B-cell precursors (BCP) in 661 bone marrow (BM) specimens by 4 color flow cytometry. Platform presentation, United States and Canadian Academy of Pathology annual meeting, San Francisco, CA, March, 1999 (Mod Pathol 1999; 12:148A)
15. Crook TW, Rogers BB, McFarland RD, Kroft SH, Latimer MJ, McKenna RW. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients. Poster presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:167A)
16. Washington LT, Aquino DB, Kroft SH, Dawson DB, McKenna RW. Immunophenotypic aberrancy in T cell large granular lymphocyte (LGL) leukemia. Poster presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:165A)
17. Xu Y, McKenna RW, Molberg KH, Kroft SH. Clinical relevance of CD10 antigen expression in de novo large B cell lymphomas. Poster presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:166A)
18. Kroft SH, Dawson DB, Howard MS, McKenna RW. Large cell transformation of chronic lymphocytic leukemia/small lymphocytic (CLL/SLL): A flow cytometric analysis of 7 cases. Poster presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:154A)
19. Asplund SL, Howard MS, McKenna RW, Kroft SH. Immunophenotype does not correlate with lymph node histology in CLL/SLL. Poster presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:142A)
20. Karandikar NJ, Aquino DB, McKenna RW, Kroft SH. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome: An immunophenotypic analysis. Platform presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:153A)
21. Jamal S, Picker LJ, Aquino DB, McKenna RW, Kroft SH. A comprehensive 4-color flow cytometric analysis of non-neoplastic T-cell populations in a variety of anatomic sites. Poster presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:152A)
22. Jamal S, Picker LJ, Aquino DB, McKenna RW, Dawson DB, Kroft SH. Immunophenotypic analysis of peripheral T-cell neoplasms: A multiparameter flow cytometric approach. Poster presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:151A)
23. Xu Y, Kroft SH, McKenna RW, Aquino DB. Prognostic significance of tumor-infiltrating T cells and T cell subsets in diffuse large B cell lymphomas: A multiparameter flow cytometry study of 55 cases. Platform presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Patho l2000;13:166A)
24. Nangia R, Kroft SH, Singleton TP, Ross CW, Finn WG, Schnitzer B. Splenic morphology in small B-cell lymphoproliferative disorders (SBL): A study of 48 well-charcaterized cases. Poster presentation, United States and Canadian Academy of Pathology annual meeting, New Orleans, LA, March, 2000 (Mod Pathol 2000;13:158A)
25. Karandikar N, Hotchkiss E, McKenna RW, Kroft SH. Transient Stress Lymphocytosis: An Immunophenotypic Characterization of the Most Common Cause of New Adult Lymphocytosis in a Tertiary Hospital. Poster presentation, American Society of Clinical Pathologists Fall Meeting, San Diego, CA, October, 2000 (Am J Clin Pathol 2000;114:649.)
26. Pullarkat VA, Buenos-Ramos C, Lai R, Kroft S, Wilson C, Pullarkat S, McCourty A, Lee M, Brynes RK. The Asp816His c-kit mutation is common in systemic mast cell disease associated with myeloid malignancy. Poster presentation, American Society of Hematology Annual Meeting, San Francisco, CA, December, 2000 (Blood 2000;96:105A)
27. Xu Y, McKenna RW, Kroft SH. Sensitivity and specificity of CD10 expression in the diagnosis of small B-cell lymphomas using multiparameter flow cytometry with cluster analysis. Platform presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, GA, March, 2001 (Mod Pathol 2001;14:183A)
28. Asplund SL, McKenna RW, Kroft SH. CD5(+) small B-cell neoplasms of indeterminate immunophenotype: a clinicopathologic analysis of 28 cases. Platform presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, GA, March, 2001 (Mod Pathol 2001;14:155A)
29. Carlile B, McKenna RW, Kroft SH. Lymphoplasmacytoid lymphoma: an immunophenotypic re-evaluation. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, GA, March, 2001 (Mod Pathol 2001;14:157A)
30. Espenshade KK, Aquino DB, McKenna RW, Kroft SH. Comparative analysis of light chain expression in germinal center cells and mantle cells of reactive lymphoid tissues: a four-color flow cytometric study. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, GA, March, 2001 (Mod Pathol 2001;14:162A)
31. Xu Y, McKenna RW, Kroft SH. Comparison of immunohistochemistry and flow cytometry with cluster analysis for the detection of CD10. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, GA, March, 2001 (Mod Pathol 2001;14:183A)
32. Sinkre PA, Kroft SH, McKenna RW, Aquino DB. Flow cytometric findings characteristic of HIV infection. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, GA, March, 2001 (Mod Pathol 2001;14:179A)
33. Maitra A, Schneider NR, Kroft SH, Winick N, McKenna RW. t(1;19) acute lymphoblastic leukemia revisited. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, GA, March, 2001 (Mod Pathol 2001;14:171A)
34. Wilson KS, McKenna RW, Kroft SH, Dawson DB, Schneider NR. Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, GA, March, 2001 (Mod Pathol 2001;14:183A)
35. Xu Y, McKenna RW, Asplund SL, Kroft SH. Immunophenotypic comparison of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Chicago, IL, February, 2002 (Mod Pathol 2002;15:271A)
36. Wright BF, McKenna RW, Asplund SL, Kroft SH. Maturing B-cell precursors in bone marrow: a detailed subset analysis of 141 cases by 4-color flow cytometry. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Chicago, IL, February, 2002 (Mod Pathol 2002;15:270A)
37. Wright BF, Asplund SL, McKenna RW, Kroft SH. Large B-cell lymphoma with discordant marrow involvement: an immunophenotypic analysis of 11 cases. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Chicago, IL, February, 2002 (Mod Pathol 2002;15:270A)
38. Paranjape GS, Asplund SL, Jamal S, McKenna RW, Kroft SH. Anaplastic large cell lymphoma: a flow cytometric analysis of 18 cases. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Chicago, IL, February, 2002 (Mod Pathol 2002;15:257A-258A)
39. Asplund SL, Karandikar N, Ansari MQ, Kroft SH, McKenna RW. Clinical and immunophenotypic analysis of natural killer cell chronic lymphoproliferations. Platform presentation, United States and Canadian Academy of Pathology annual meeting, Chicago, IL, February, 2002 (Mod Pathol 2002;15:229A)
40. Asplund SL, McKenna RW, Kroft SH. Immunophenotypic changes over time in chronic lymphocytic leukemia appear random. Platform presentation, United States and Canadian Academy of Pathology annual meeting, Chicago, IL, February, 2002 (Mod Pathol 2002;15:229A)
41. McKenna RW, Asplund SL, Kroft SH. All cases of precursor B ALL exhibit multiple immunophenotypic aberrancies by flow cytometry with cluster analysis. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Chicago, IL, February, 2002 (Mod Pathol 2002;15:255A)
42. Chen W, Asplund SL, McKenna RW, Kroft SH. Clinical significance of incidentally identified minute clonal B-lymphocyte populations in peripheral blood and bone marrow. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Washington, D.C., March, 2003 (Mod Pathol 2003;16:227A)
43. Willis MS, McKenna RW, Peterson LC, Kroft SH. Low blast count myelodysplastic syndrome with Auer rods: a clinicopathologic analysis of 6 cases. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Washington, D.C., March, 2003 (Mod Pathol 2003;16:259A)
44. Asplund SL, McKenna RW, Shen Y-M, Kroft SH. Plasmablastic lymphoma in non-oral sites: immunophenotypic, molecular, and cytogenetic characterization of three cases. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Washington, D.C., March, 2003 (Mod Pathol 2003;16:225A)
45. Reichard KK, McKenna RW, Kroft SH. ALK-positive large B-cell lymphoma: a report of three cases. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Washington, D.C., March, 2003 (Mod Pathol 2003;16:250A)
46. Kroft SH, Karandikar NJ, McKenna RW, Asplund SL. Circulating hematogones in adults: a 4-color flow cytometry study of 102 patients. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Washington, D.C., March, 2003 (Mod Pathol 2003;16:241A)
47. Xu Y, McKenna RW, Doolittle JE, Hladik CL, Kroft SH. BCL2 rearrangement may define a distinct subset of de novo diffuse large B-cell lymphoma. Platform presentation, United States and Canadian Academy of Pathology annual meeting, Washington, D.C., March, 2003 (Mod Pathol 2003;16:260A)
48. Monaghan SA, Kroft SH, McKenna RW. 11 cases of extranodal NK/T-cell lymphoma, nasal type from a single U.S. medical center with emphasis on flow cytometry analysis. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Washington, D.C., March, 2003 (Mod Pathol 2003;16:245A)
49. Chen W, Karandikar NJ, McKenna RW, Kroft SH. Stability of leukemia-associated immunophenotypes in precursor B-cell acute lymphoblastic leukemiaL a single institution experience. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Vancouver, March, 2004 (Mod Pathol 2004;17(Supp 1):243A)
50. Chen W, Karandikar NJ, McKenna RW, Kroft SH. Flow cytometric features of angioimmunoblastic T-cell lymphoma. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Vancouver, March, 2004 (Mod Pathol 2004;17(Supp 1):243A)
51. Hussey SM, Karandikar NJ, McKenna RW, Kroft SH. Immunophenotypic changes in peripheral T-cell lymphoma over time. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Vancouver, March, 2004 (Mod Pathol 2004;17(Supp 1):252A)
52. Kesler MV, Kroft SH, Karandikar NJ, McKenna RW, Hladik CL, Xu Y. Dual-labelling immunohistochemistry for CD10, bcl-6, and MUM-1 in diffuse large B-cell lymphoma. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Vancouver, March, 2004 (Mod Pathol 2004;17(Supp 1):254A)
53. Shivapurkar N, Stastny V, Reddy JL, Takahashi T, Suzuki M, Kroft SH, McKenna RW, Gazdar AF. Novel real time PCR assay using a universal molecular marker for diagnosis of hematologic cancer and identification of minimal residual disease. Presented at American Association for Cancer Research annual meeting, Orlando, March, 2004 (Proc Amer Assoc Cancer Res 2004;45)
54. Kapur P, Kroft SH, Molberg KH, Hoang M. Solitary plasmacytoma of the thyroid gland: a case report. Poster presentation, Texas Society of Pathologists Annual Meeting, Dallas, January, 2004
55. Fuda FS, Kroft SH, Alfardan JM, Xu Y, McKenna RW, Karandikar NJ. Myeloperoxidase Expression Differentiates Leukemic From Non-Leukemic Blasts. Poster presentation, United States and Canadian Academy of Pathology annual meeting, San Antonio, February/March, 2005 (Mod Pathol 2005;18(Supp 1):230A
56. Alfardan JM, Kroft SH, Fuda FS, Xu Y, McKenna RW, Karandikar NJ. Immunophenotypic Comparison of Peripheral Blood Stem Cells, Normal Bone Marrow Blasts and Leukemic Myeloid Blasts. Poster presentation, United States and Canadian Academy of Pathology annual meeting, San Antonio, February/March, 2005 (Mod Pathol 2005;18(Supp 1):220A)
57. Xu Y, McKenna RW, Wilson KS, Karandikar NJ, Schultz RA, Kroft SH. Immunophenotypic identification of acute myeloid leukemia with monocytic differentiation. Platform presentation, United States and Canadian Academy of Pathology annual meeting, San Antonio, February/March, 2005 (Mod Pathol 2005;18(Supp 1):258A)
58. Xu Y, McKenna RW, Karandikar NJ, Pildain AJ, Kroft SH. Flow cytometric analysis of monocytosis in the diagnosis of chronic myelomonocytic leukemia. Poster presentation, United States and Canadian Academy of Pathology annual meeting, San Antonio, February/March, 2005 (Mod Pathol 2005;18(Supp 1):258A)
59. Isaacson TV, Kroft SH, McKenna RW. Cleaved caspase-3 expression in hematopoietic marrow in T-cell large granular lymphocytic leukemia. Poster presentation, United States and Canadian Academy of Pathology annual meeting, San Antonio, February/March, 2005 (Mod Pathol 2005;18(Supp 1):235A)
60. Chenault C, Karandikar NJ, Xu Y, McKenna RW, Kroft SH. Rituxan effect on hematogones in bone marrow. Poster presentation, United States and Canadian Academy of Pathology annual meeting, San Antonio, February/March, 2005 (Mod Pathol 2005;18(Supp 1):225A)
61. Pildain A, McKenna RW, Kroft SH. Extranodal marginal zone lymphoma involving peripheral blood: a report of 4 cases. Poster presentation, United States and Canadian Academy of Pathology annual meeting, San Antonio, February/March, 2005 (Mod Pathol 2005;18(Supp 1):246A)
62. Kesler MV, Xu Y, Karandikar NJ, McKenna RW, Kroft SH. Flow cytometric comparison of Burkitt and CD10(+) large B-cell lymphomas. Platform presentation, United States and Canadian Academy of Pathology annual meeting, San Antonio, February/March, 2005 (Mod Pathol 2005;18(Supp 1):237A)
63. Seegmiller A, Karandikar NJ, Kroft SH, McKenna RW, Xu Y. Over-expression of CD7 in CD4+ T cells in Classic Hodgkin Lymphoma. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Atlanta, February, 2006
64. Harrington A, Ward. PCJ, Kroft SH. Iron deficiency anemia, beta thalassemia minor, and anemia of chronic disease: a morphologic reappraisal. Poster presentation, ASCP annual meeting, Las Vegas, October, 2006 (Am J Clin Pathol 2006;126:644-645)
65. Benjamin HL, Fenske TS, Kroft SH, Hohenwalter EJ, Rilling. Treatment of diffuse large B-cell lymphoma of the liver with yttrium-90 microsphere embolization. Poster presentation, American Society of Hematology Annual Meeting, Atlanta, December, 2007 (Blood 2007;110:200B)
66. Olteanu H, Karandikar NJ, Kroft SH. Clinical and laboratory findings in CD4(+) large granular lymphocyte leukemia. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Denver, March, 2008 (Mod Pathol 2008;21(Supp 1):268A)
67. Firchau DJ, Straus T, Kroft S, Alexander RT. Sudden cardiac death due to non-Hodgkin lymphoma micrometastasis to the atrioventricular node. Accepted for platform presentation, National Association of Medical Examiners annual meeting, Louisville, September, 2008
68. Harrington AM, Kroft SH. Utility of CD56 Immunohistochemistry in Follow-Up of Plasma Cell Myeloma. Finalist, AJCP Resident Research Symposium, ASCP annual meeting, Baltimore, October, 2008 (Am J Clin Pathol 2008;130:649)
69. Harrington AM, Olteanu H, Kroft SH. The specificity of immunophenotypic alterations in blasts in non-acute myeloid disorders. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Boston, March, 2009 (Mod Pathol 2009;22(Supp 1):265A)
70. Walters MP, Olteanu H, Van Tuinen P, Kroft SH. CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukemia in this cytogenetic sub-group. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Boston, March, 2009 (Mod Pathol 2009;22(Supp 1):289A)
71. Olteanu H, Hari P, Schur BC, Kroft SH. Expression of natural killer receptors in T lymphocytes and NK cells post stem cell transplantation. Poster presentation, United States and Canadian Academy of Pathology annual meeting, Boston, March, 2009 (Mod Pathol 2009;22(Supp 1):385A)
72. Finn WG, Carter KM, Raich R, Harrington AM, Kroft SH, Hero AO. Flow cytometric evaluation of reactive and dysplastic granulocyte maturation by a novel method of high dimensional data analysis. Platform presentation, United States and Canadian Academy of Pathology annual meeting, Boston, March, 2009 (Mod Pathol 2009;22(Supp 1):381A)
73. Rathke S, Harrington A, Olteanu H, Kroft S, del Rosario S, Ho K-C. Rapidly Progressive Fatal Dementia Secondary to Lymphomatosis Cerebri. Poster presentation, College of American Pathologists annual meeting, Washington, D.C., October, 2009
74. Connelly J, Harrington A, Kroft S, Ho K-C, Fenske T, Malkin M. Methotrexate-Induced CNS Hodgkin-like Lymphoproliferative Disorder: A Case Report. Poster presentation, Joint Meeting of the Society for Neuro-Oncology and the AANS/CNS Section, New Orleans, October, 2009 (Neuro-Oncology 2009;11:620)
75. Harrington AM. Olteanu H, Currey A, Kroft SH. Localized bone marrow aplasia following radiation with discrepant peripheral counts: A study of 7 cases. Poster presentation, ASCP annual meeting, Chicago, October, 2009 (Am J Clin Pathol 2009;132:631)
76. Olteanu H, Harrington AM, George B, Hari P, Bredeson C, Kroft SH. High Prevalence of Dapsone-Induced Oxidant Hemolysis in North American Stem Cell Transplant Recipients Without Glucose-6-Phosphate-Dehydrogenase Deficiency. Poster presentation, American Society of Hematology Annual Meeting, New Orleans, December, 2009 (Blood 2009;114:1285)
77. Harrington AM, Olteanu H, Kroft SH. A dissection of the CD45/SS (SS) blast gate in non-acute myeloid disorders and non-neoplastic bone marrows. Poster presentation, USCAP annual meeting, Washington, D.C., March, 2010 (Mod Pathol, 2010;23:301A)
78. Vaughan J, Olteanu H, Wimpee B, Kroft SH, Jarzembowski JA. The Regulatory T-Lymphocyte Content of Post-Transplant Lymphoproliferative Disorders. Poster presentation, USCAP annual meeting, Washington, D.C., March, 2010 (Mod Pathol, 2010;23:326A)
79. Harrington AM, Olteanu H, Kroft SH. Incidental, immunophenotypically aberrant cytotoxic T-cell clones in patients with other hematologic malignancies. Poster presentation, USCAP annual meeting, Washington, D.C., March, 2010 (Mod Pathol, 2010;23301A)
80. Spears MD, Harrington AM, Kroft SH, Olteanu H. Immunophenotypic stability of T-cell large granular lymphocytic leukemia and chronic lymphoproliferative disorders of NK cells by flow cytometry. Poster presentation, USCAP annual meeting, Washington, D.C., March, 2010 (Mod Pathol, 2010;23:323A)
81. Spears MD, Olteanu H, Kroft SH, Harrington AM. Immunophenotypic stability in plasma cell myeloma by flow cytometry. Poster presentation, USCAP annual meeting, Washington, D.C., March, 2010 (Mod Pathol, 2010;23:323A)
82. Olteanu H, Harrington AM, Kroft SH. The role of flow cytometry in the diagnosis of intraocular lymphoma. Poster presentation, USCAP annual meeting, Washington, D.C., March, 2010 (Mod Pathol, 2010;23:383A)
83. Olteanu H, Harrington AM, Kroft SH. CD23(+) follicular lymphoma: immunophenotypic and clinical features. Poster presentation, USCAP annual meeting, Washington, D.C., March, 2010 (Mod Pathol, 2010;23:315A)
84. Olteanu H, Harrington AM, Kroft SH. Time and temperature stability of T-cell subsets. Poster presentation, USCAP annual meeting, Washington, D.C., March, 2010 (Mod Pathol, 2010;23:436A)
85. Cogbill CH, Gupta S, Kroft SH, Gheorghe G. Lung involvement by nodular lymphocyte predominant Hodgkin lymphoma and concurrent Mycobacterium avium complex infection. Poster presentation, ASCP annual meeting, San Francisco, October, 2010
86. K Annen, T Straus, C Altmann, S. Kroft, M Horowitz, K Friedman, J Gottschall, C Eshoa. Two Cases of Transfusion-Transmitted Anaplasma phagocytophilum. Poster presentation, AABB annual meeting, Baltimore, October, 2010 (Transfusion 2010;50(Supp 2):200A-201A
87. Georghe G, Rangarajan HG, Reiswig A, Segura A, Kroft S, Southern J. Pediatric T cell-rich large B-cell lymphoma: an under-recognized entity? Poster presentation, Banff Pathology Course, Alberta, September, 2010
88. Olteanu H, Harrington A, Kroft S. CD200 expression in plasma cell myeloma. Platform presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):312A-313A)
89. Harrington A, Olteanu H, Kroft S. The unique immunophenotype of “double hit lymphomas.” Poster presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):300A)
90. Rathke S, Olteanu H, Kroft S, Harrington A. CD45 expression in plasma cell myeloma. Poster presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):317A)
91. Chang J, Harrington A, Olteanu H, Kroft S. Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma. Poster presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):289A)
92. Cogbill C, Spears M, Harrington A, Olteanu H, Kroft S. Analysis of variables affecting the flow cytometric recovery of plasma cell myeloma in bone marrow aspirates. Poster presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):291A)
93. Schur B, Harrington A, Kroft S, Olteanu H. Lymphocyte subset reference ranges for evaluation of immune reconsitution after allogeneic stem cell transplantation. Poster presentation, USCAP annual meeting, San Antonio, February/March, 2011(Mod Pathol 2011;24(Supp 1):455A)
94. Horna P, Olteanu H, Kroft S, Harrington A. Flow cytometric analysis of light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies. Poster presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):301A-302A)
95. Buonaccorsi J, Kroft S, Harrington A, Olteanu H. Clinicopathologic analysis of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32). Poster presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):288A)
96. Bieliauskas S, Bacon C, Foucar K, Gibson S, Kroft S, Swerdlow S, Eshoa C, Cook J. Gamma heavy chain disease: a morphologic and immunophenotypic study of 10 cases including bone marrow, lymph nodes, and spleen. Platform presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):287A)
97. Vaughan J, Harrington A, Kroft S, Olteanu H. Immunophenotypic Stability of Sezary Cells by Flow Cytometry. Poster presentation, USCAP annual meeting, San Antonio, February/March, 2011 (Mod Pathol 2011;24(Supp 1):326A)
98. Brinkerhoff BT, Kroft SH, Rao RN. Diffuse Alveolar Septal AA Amyloidosis in the Setting of Multiple Myeloma. Poster Presentation CAP Annual Meeting, Dallas, October, 2011
99. Horna P, Kroft SH, Harrington AM, Olteanu H. Persistence of Residual Normal Peripheral Blood B Cells in Newly Diagnosed Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL) Identifies a Good Prognostic Subgroup. Poster Presentation, USCAP Annual Meeting, Vancouver, March, 2012 (Mod Pathol 2012;24(Supp 2):341A)
100. Rathke SK, Olteanu H, Kroft SH, Harrington AM. Morphologic Changes in Myelodysplastic Syndrome Treated with Hypomethylating Agents. Poster Presentation, USCAP Annual Meeting, Vancouver, March, 2012 (Mod Pathol 2012;24(Supp 2):364A)
101. Harrington AM, Olteanu H, Kroft SH. Most Diffuse Large B-cell Lymphomas Are Identified by Flow Cytometry. Poster Presentation, USCAP Annual Meeting, Vancouver, March, 2012 (Mod Pathol 2012;24(Supp 2):339A)
102. Olteanu H, Harrington AM, Kroft SH, Karandikar NJ, Fuda FF. The Prevalence of CD56 Expression by Flow Cytometry in Acute Promyelocytic Leukemia Patients Treated with All-Trans Retinoic Acid and Anthracycline Drug Combinations. Poster Presentation, USCAP Annual Meeting, Vancouver, March, 2012 (Mod Pathol 2012;24(Supp 2):359A)
103. Olteanu H, Harrington AM, Kroft SH. CD200 Expression in Non-Myeloma Immunoproliferative Disorders. Poster Presentation, USCAP Annual Meeting, Vancouver, March, 2012 (Mod Pathol 2012;24(Supp 2):358A-359A)
104. Vaughan J, Olteanu H, Kroft SH, Harrington AM. Blast Immunophenotypes by Flow Cytometry in Acute Myeloid Leukemia With Myelodysplasia-Related Changes. Poster Presentation, USCAP Annual Meeting, Vancouver, March, 2012 (Mod Pathol 2012;24(Supp 2):377A)
105. Vaughan J, Olteanu H, Kroft SH, Harrington AM. Flow Cytometric Blast Immunophenotype in Acute Myeloid Leukemias Arising from Non-Acute Myeloid Disorders. Poster Presentation, USCAP Annual Meeting, Vancouver, March, 2012 (Mod Pathol 2012;24(Supp 2):378A)
106. Parsons LN, Olteanu H, Kroft SH, Harrington AM. Megakaryocytic Hyperplasia Associated With Granulocyte-Colony Stimulating Factor. Poster Presentation, USCAP Annual Meeting, Vancouver, March, 2012 (Mod Pathol 2012;24(Supp 2):360A)
107. Vaughan J, Kroft SH, Olteanu H, Hess MA, Miller R, Harrington AM. A Retrospective Analysis of Pathology Review Criteria for Peripheral Blood and Body Fluids: One Institution's Experience. Poster Presentation, ASCP Annual Meeting, Boston, October/November, 2012
108. Vaughan J, MacKinnon AC, Harrington AM, Kroft SH, Olteanu H. CD200 Expression in Post-Transplant Lymphoproliferative Disorders Correlates With an Increased Frequency of FoxP3(+) Regulatory T-Cells. Poster Presentation, USCAP Annual Meeting, Baltimore, March, 2013 (Mod Pathol 2013:26(Supp 2):265A).
109. Rathke SK, Chang JC, Harrington AM, Olteanu H, Kroft SH. The immunophenotype of prolymphocytoid transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) revisited. Poster Presentation, USCAP Annual Meeting, Baltimore, March, 2013 (Mod Pathol 2013;26(Supp 2):356A-357A).
110. Rathke SK, Harrington AM, Olteanu H, Kroft SH. Dim CD33 Expression in Myelomonocytic Marrow Elements: A Novel Description of an Apparently Normal Variant. Poster Presentation, USCAP Annual Meeting, Baltimore, March, 2013 (Mod Pathol 2013;26(Supp 2):357A).
111. Schumann J, Harrington AM, Kroft SH, Olteanu H. NK Cell Reference Ranges Established by Flow Cytometry in Reactive and Lymphomatous Lymph Nodes. Poster Presentation, USCAP Annual Meeting, Baltimore, March, 2013 (Mod Pathol 2013;26(Supp 2):360A).
112. Hintzke M, Olteanu H, Kroft SH, Harrington AM. CD30 Expression in Non-Hodgkin B-Cell Lymphoma. Poster Presentation, USCAP Annual Meeting, Baltimore, March, 2013 (Mod Pathol 2013;26(Supp 2):331A-332A).
113. Vaughan J, Harrington AM, KROFT SH, Olteanu H. Immunophenotypic Analysis of Mycosis Fungoides in Large Cell Transformation. Poster Presentation, ASCP Annual Meeting, Chicago, September, 2013.
114. Li H, KROFT SH. Severe Pernicious Anemia With Normal Serum B12 and Normal MCV. Poster Presentation, ASCP Annual Meeting, Chicago, September, 2013.
115. Ordobazari A, Olteanu H, KROFT SH, Harrington AM. A Comparison of Therapy-Related and De Novo Chronic Myelomonocytic Leukemia. Poster presentation, USCAP Annual Meeting, San Diego, March, 2014 (Mod Pathol 2014;27(Supp 2):357A-358A).
116. Li H, KROFT SH, Harrington AM, Hosking P, Olteanu H. Pure Erythroid Leukemia Evolving from Chronic Myeloid Neoplasms: A Report of 3 Cases. Poster presentation, USCAP Annual Meeting, San Diego, March, 2014 (Mod Pathol 2014;27(Supp 2):369A).
117. Hintzke M, Olteanu H, KROFT SH, Harrington AM. Sensitivity & Specificity of Peripheral Blood Findings in Screening for Myelodysplastic Syndrome. Poster presentation, ASCP Annual Meeting, Tampa, October, 2014.
118. Batdorf B, KROFT SH, Olteanu H, Harrington AM. Reactive Bone marrow Plasmacytosis: An Update for the Modern Era. Poster presentation, ASCP Annual Meeting, Tampa, October, 2014.
119. Parsons LN, KROFT SH, Harrington AM, Olteanu H. Flow Cytometric Analysis of CD23 and FMC-7 Expression in Diffuse Large B-Cell Lymphoma. Poster presentation, International Clinical Cytometry Society Meeting, Seattle, October, 2014.
120. Hartley C, Hintzke M, Vaughan J, Hosking P, Harrington A, KROFT SH, Olteanu H. CD30 expression in post-transplant lymphoproliferative disorders. Poster presentation, USCAP Annual Meeting, Boston, March, 2015 (Mod Pathol 2015;28(Supp 2):349A).
121. Robin A, KROFT SH, Harrington A, Hosking P, Olteanu H. Evaluation of proliferation index in lymph nodes with CLL/SLL. Poster presentation, USCAP Annual Meeting, Boston, March 2015 (Mod Pathol 2015:28(Supp2):374A).
122. Li H, KROFT SH, Hosking P, Harrington A, Olteanu H. CD38 expression in follicular lymphoma correlates with histologic grade. Poster presentation, USCAP Annual Meeting, Boston, March, 2015 (Mod Pathol 2015;28(Supp 2):359A.
123. Harrington AM, Hosking P, Olteanu H, KROFT SH. Unique aberrant myeloblast immunophenotype associated with azathioprine therapy. Poster presentation, USCAP Annual Meeting, Boston, March 2015 (Mod Pathol 2015;28(Supp 2):349A).
124. Harrington AM, Hosking P, Olteanu H, KROFT SH. CD3 staining on myeloid elements in acute myeloid leukemia bone marrows. Poster presentation, USCAP Annual Meeting, Boston, March, 2015 (Mod Pathol 2015;28(Supp 2):348A).
125. Hintzke M, Harrington AM, Olteanu H, Hosking P, KROFT SH. Bone marrow monocytosis: A survey of 150 cases. Accepted for poster presentation, ASCP Annual Meeting, Long Beach, CA, 10/2015.
126. Schelling LA, Ordobazari A, KROFT SH, Olteanu H, Hosking P, Harrington A. Immunophenotypic Comparisonof Dysplastic and Proliferative Subtypes of Chronic Myelomonocytic Leukemia by Flow Cytometry. Accepted for poster presentation, ASCP Annual Meeting, Long Beach, CA, 10/2015.
127. Mostafa M, Hartley C, Kroft SH, Harrington AM. The Utility of Flow Cytometry in Cerebrospinal Fluid Diagnosis. Accepted for platform presentation, USCAP Annual Meeting, National Harbor, March, 2019.
128. Abbott D, Carrillo LP, Kroft SH, Cunningham AM, Astle J, Harrington AM. Flow Cytometric Assessment of CD10 as a Surrogate for Immunohistochemistry in Cell of Origin (COO) Subtyping of Diffuse Large B-cell Lymphoma (DLBCL). Accepted for presentation, USCAP Annual Meeting, National Harbor, March, 2019.
129. Carrillo LF, Harrington AM, Astle J, Cunningham AM, Kroft SH. Distinct Patterns of Antigen Expression on Peripheral Blood (PB) Myeloblasts By Flow Cytometry (FC) At Diagnosis of Adult B-Lymphoblastic Leukemia/Lymphoma (B-ALL): A Pitfall in the Differential Diagnosis with Mixed Phenotype Acute Leukemia (MPAL). Accepted for presentation, USCAP Annual Meeting, National Harbor, March, 2019.
130. Zhang L, Stablein DM, Epling-Burnette PK, Harrington AM, Moscinski LC, Kroft SH, Thomas JW, DeZern AE, Al-Baghdadi T, Liu JJ, Walter MJ, Bejar R, Gorak EJ, Abel GA, Scott BL, Sekeres MA. Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance Between Local And Central Review In The NHLBI MDS Natural History Study. Accepted for poster presentation, ASH Annual Meeting, San Diego, December, 2018.
131. Arispe K, Gannon V, Albright T, Kroft SH, Cunningham A, Astle J, Harrington Am. Utility of Physician Requested Manual Differentials in peripheral blood samples: An Institutional Experience for Quality Improvement. Poster presentation, ASCP Annual Meeting, Baltimore, October, 2018.
132. Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM. Carcinocythemia: A Rare Entity Becoming More Common? A 3-year, Single Institution Series of Seven Cases and Literature Review. Poster presentation, ASCP Annual Meeting, Baltimore, October, 2018.
133. Hopp A, Harrington AM, Olteanu H, Kroft SH. Comparative Evaluation of Plasmacytoid Dendritic Cell Content in Reactive and Neoplastic Lymphoid Aggregates in Bone Marrow. Poster presentation, USCAP Annual Meeting, Vancouver, March, 2018 (Mod Pathol 2018;31(Supp 2):522).
134. Carrillo L, Harrington AM, Olteanu H, Kroft SH. Evaluation of Extranodal Marginal Zone B Cell Lymphoma by Flow Cytometry. Poster presentation, USCAP Annual Meeting, Vancouver, March, 2018 (Mod Pathol 2018;31(Supp 2):503-4).
135. Carrillo L, Mendoza D, Harrington AM, Kroft SH. Computer-Based Differential Tally Counter for Bone Marrows. Poster presentation, USCAP Annual Meeting, Vancouver, March, 2018 (Mod Pathol 2018;31(Supp 2):585).
136. Olteanu H, Knous K, Hosking P, Harrington A, Kroft S. Prevalence and Diagnostic Utility of Dutcher Bodies in Orbital Biopsies Bodies in Orbital Biopsies. Poster Presentation, CAP Annual Meeting, National Harbor, MD, October, 2017.
137. Batdorf B, Kroft S, Olteanu H, Harrington A, Hosking P. Correlation of Bruton’s Tyrosine Kinase Expression in Classical Hodgkin Lymphoma and its relationship to EBV infection. Poster Presentation, USCAP Annual Meeting, Seattle, March, 2016 (Mod Pathol 2016;29(Supp 2):335A).
138. Olteanu H, Wadzanai M, Tarakanova V, Hosking P, Harrington A, Kroft S. Tumor Suppressor IRF­1 Expression is Decreased in Post­Transplant Lymphoproliferative Disorder. Poster Presentation USCAP Annual Meeting, Seattle, March, 2016 (Mod Pathol 2016;29(Supp 2):366A).
139. Olteanu H, Hosking P, Harrington A, Kroft S. PD­L1 Expression Correlates with EBV Status in Post­Transplant Lymphoproliferative Disorders. Poster presentation USCAP Annual Meeting, Seattle, March, 2016 (Mod Pathol 2016;29(Supp 2):366A).
 
Database, Video, or Other Research/Clinical Contributions
1. Pathologic Basis of Disease, Interactive Case Study CD Companion, 7th Edition, Elsevier Saunders, 2004